pre-miRNA Information
pre-miRNA hsa-mir-508   
Genomic Coordinates chrX: 147236913 - 147237027
Synonyms MIRN508, hsa-mir-508, MIR508
Description Homo sapiens miR-508 stem-loop
Comment None
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-508-3p
Sequence 61| UGAUUGUAGCCUUUUGGAGUAGA |83
Evidence Experimental
Experiments Array-cloned
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1388853184 18 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol TMEM189-UBE2V1   
Synonyms CROC-1B, CROC1B, KUA-UEV
Description TMEM189-UBE2V1 readthrough
Transcript NM_199203   
Expression
Putative miRNA Targets on TMEM189-UBE2V1
3'UTR of TMEM189-UBE2V1
(miRNA target sites are highlighted)
>TMEM189-UBE2V1|NM_199203|3'UTR
   1 TCAAAAAGAAAAACCACAGGCCCTTCCCCTTCCCCCCAATTCGATTTAATCAGTCTTCATTTTCCACAGTAGTAAATTTT
  81 CTAGATACGTCTTGTAGACCTCAAAGTACCGGAAAGGAAGCTCCCATTCAAAGGAAATTTATCTTAAGATACTGTAAATG
 161 ATACTAATTTTTTGTCCATTTGAAATATATAAGTTGTGCTATAACAAATCATCCTGTCAAGTGTAACCACTGTCCACGTA
 241 GTTGAACTTCTGGGATCAAGAAAGTCTATTTAAATTGATTCCCATCATAACTGGTGGGGCACATCTAACTCAACTGTGAA
 321 AAGACACATCACACAATCACCTTGCTGCTGATTACACGGCCTGGGGTCTCTGCCTTCTCCCCTTACCCTCCCGCCTCCCA
 401 CCCTCCCTGCAACAACAGCCCTCTAGCCTGGGGGGCTTGTTAGAGTAGATGTGAAGGTTTCAGGTCGCAGCCTGTGGGAC
 481 TACTGCTAGGTGTGTGGGGTGTTTCGCCTGCACCCCTGGTTTCTTTAAGTCTTAAGTGATGCCCCTTCCAAACCATCATC
 561 CTGTCCCCACGCTCCTCCACTCCCGCCCTTGGCCGAAGCATAGATTGTAACCCCTCCACTCCCCTCTGAGATTGGCCTTC
 641 GGTGAGGAATTCAGGGCTTTCCCCATATCTTCTCTCCCCCACCTTTATCGAGGGGTGCTGCTTTTTCTCCCTCCTCCTCA
 721 AGTTCCTTTTTGCACCGTCACCACCCAACACCTTCCATGACACTTCCTTGCTTTGGCCAGAAGCCATCAGGTAAGGTTGG
 801 AAAGAGCCTCTGACCTCCCTTGTTTAGTTTTGGAACCATACTCACTCACTCTCCACCAGCCTGGGAAATGAATATTGGGT
 881 CCTCAGCCCTGCCACCCTCTGCTGTCATCAGCTGATGCATTGTTTTTAGCTCAGGTTTTGATAAGGTGAAAAGAATAGTC
 961 ACCAGGGTTACTCAGACCTGCCAGCTCTCGGAGTCCTTGGTGGTTGAACTTGGAGAAAGACCGCATGAAGATACTTGTAA
1041 GCACACATGATCCCTCTGAATTGTTTTACTTTCCTGTAACTGCTTTTGCTTTTAAAAATTGAAGAAGTTTTAAACAGGGC
1121 TTTCATTTGGTCATCCTTGCAATCCATTGGGGTCTAGTTTGGAATCTGACAACTGGAACAAAAAGAACCTTGAATCCGGT
1201 GCATGCCTTGGTTTTGGTGCTGCTGCTGCTTCCCAAGATCCTCAGCAGGGATTAAGAAGGAACCCGGTGTGCACAGCAGA
1281 TCCCCGAAATTGGTGGGCTTGACCTCCTGGCAAATTGCTGCGTCTTTCCACTTGCTGTTCAGGACCACTAAATGCTGAAA
1361 TGTGGATGCATACCGAAATAAAAGCAATTCATTGTGTACTAAAGGTTTTTTTTTTTTTTTTAATTTAGTATTTGTGTAAA
1441 ACCACCTTTTGAAGCAGCAACTATCAAGTCTGAAAAGCAATTGATGTTTCCATTAATCTTTTTCTGGGGGGAAAACCTTA
1521 GTTCTAAGGATTTAACATCCTGTAAGTGAAGTTTAACATAACAGTATTCCATAAGCAGCCTTTTTATTGTCAGACCATTG
1601 CCTGATTTTAATATAATAAAAAAAAAGTGTGCGTTAATATTTAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' agaugagguuuuccGAUGUUAGu 5'
                        :|:||||| 
Target 5' tcatttggtcatccTTGCAATCc 3'
1123 - 1145 125.00 -7.50
2
miRNA  3' agaUGA-GGUUUUCCG------AUGUUAGu 5'
             ||| : ||||| |       |||||| 
Target 5' tcaACTGTGAAAAGACACATCACACAATCa 3'
310 - 339 122.00 -9.40
3
miRNA  3' agAUGAGGUUUUCCGAUG-UUAGu 5'
            |||| : ||| | ||| |||: 
Target 5' gaTACTGT-AAATGATACTAATTt 3'
148 - 170 116.00 -6.60
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN24307096 3 COSMIC
COSN26998937 22 COSMIC
COSN30476187 28 COSMIC
COSN30505513 31 COSMIC
COSN30458627 32 COSMIC
COSN30458620 33 COSMIC
COSN30169210 52 COSMIC
COSN31567363 75 COSMIC
COSN13867558 88 COSMIC
COSN26998936 89 COSMIC
COSN30144721 107 COSMIC
COSN30502742 112 COSMIC
COSN30184289 115 COSMIC
COSN31559335 244 COSMIC
COSN28824255 287 COSMIC
COSN26563719 360 COSMIC
COSN28677500 382 COSMIC
COSN26325394 427 COSMIC
COSN22596479 456 COSMIC
COSN31579035 497 COSMIC
COSN31519043 505 COSMIC
COSN31512891 513 COSMIC
COSN28648771 522 COSMIC
COSN8000421 570 COSMIC
COSN26665932 737 COSMIC
COSN26665931 752 COSMIC
COSN21694650 755 COSMIC
COSN26646230 761 COSMIC
COSN31608558 764 COSMIC
COSN26665930 788 COSMIC
COSN9141735 827 COSMIC
COSN26644422 881 COSMIC
COSN26637891 882 COSMIC
COSN31585404 906 COSMIC
COSN26580109 945 COSMIC
COSN31484609 1058 COSMIC
COSN8899531 1144 COSMIC
COSN30176705 1286 COSMIC
COSN28402157 1322 COSMIC
COSN26548224 1348 COSMIC
COSN31596053 1392 COSMIC
COSN31529740 1404 COSMIC
COSN19660945 1406 COSMIC
COSN31518694 1441 COSMIC
COSN31529170 1498 COSMIC
COSN23222315 1617 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1327160254 7 dbSNP
rs750111448 8 dbSNP
rs765043055 13 dbSNP
rs761226884 15 dbSNP
rs1472196388 16 dbSNP
rs1363988460 18 dbSNP
rs1183602229 20 dbSNP
rs200602780 21 dbSNP
rs528812995 23 dbSNP
rs1214104193 26 dbSNP
rs1469722543 27 dbSNP
rs760688909 28 dbSNP
rs201295239 29 dbSNP
rs187204768 32 dbSNP
rs1262699317 33 dbSNP
rs773415961 35 dbSNP
rs1194254182 36 dbSNP
rs779631764 36 dbSNP
rs1376444799 38 dbSNP
rs371693730 39 dbSNP
rs899700274 40 dbSNP
rs748150641 42 dbSNP
rs368141343 43 dbSNP
rs1005431935 56 dbSNP
rs780048962 58 dbSNP
rs1351757693 61 dbSNP
rs182869336 71 dbSNP
rs557493991 88 dbSNP
rs1369437294 89 dbSNP
rs1242899650 93 dbSNP
rs73611765 104 dbSNP
rs73611764 110 dbSNP
rs1366614450 111 dbSNP
rs1270503795 112 dbSNP
rs1432674901 115 dbSNP
rs1343596496 121 dbSNP
rs1049065708 124 dbSNP
rs1448546963 130 dbSNP
rs929329105 135 dbSNP
rs897810106 139 dbSNP
rs1056989975 144 dbSNP
rs527244006 152 dbSNP
rs939444041 153 dbSNP
rs1416251387 170 dbSNP
rs544387060 172 dbSNP
rs1377397162 175 dbSNP
rs577095993 180 dbSNP
rs1172293414 189 dbSNP
rs148757188 198 dbSNP
rs191054982 208 dbSNP
rs1449714514 210 dbSNP
rs1330103976 214 dbSNP
rs41283596 215 dbSNP
rs1474636788 229 dbSNP
rs73611763 237 dbSNP
rs946969330 238 dbSNP
rs915467088 253 dbSNP
rs1272049911 261 dbSNP
rs1331994721 265 dbSNP
rs1200527091 266 dbSNP
rs988379194 268 dbSNP
rs1437104695 280 dbSNP
rs1179400646 283 dbSNP
rs554507531 288 dbSNP
rs1029326485 303 dbSNP
rs976940985 314 dbSNP
rs1467243302 315 dbSNP
rs1169053770 319 dbSNP
rs1396425563 338 dbSNP
rs1485693876 341 dbSNP
rs1408641796 355 dbSNP
rs963794287 357 dbSNP
rs1356483318 358 dbSNP
rs1018084315 361 dbSNP
rs1292292850 365 dbSNP
rs1353088599 367 dbSNP
rs1219950926 368 dbSNP
rs1251317536 378 dbSNP
rs8585 382 dbSNP
rs1193955471 383 dbSNP
rs775806445 384 dbSNP
rs1485858324 389 dbSNP
rs1025541554 392 dbSNP
rs1255651312 396 dbSNP
rs1478890544 396 dbSNP
rs1216093844 401 dbSNP
rs1372533106 406 dbSNP
rs144341721 413 dbSNP
rs1447090241 418 dbSNP
rs1277771319 420 dbSNP
rs1174801340 426 dbSNP
rs1376519226 430 dbSNP
rs897855587 443 dbSNP
rs1311381438 445 dbSNP
rs73611762 458 dbSNP
rs149631469 466 dbSNP
rs1383519690 467 dbSNP
rs879941567 478 dbSNP
rs1311098113 479 dbSNP
rs1225201538 482 dbSNP
rs1056436022 483 dbSNP
rs1305530392 490 dbSNP
rs1348394533 494 dbSNP
rs1209902067 498 dbSNP
rs1465608196 505 dbSNP
rs747116362 506 dbSNP
rs1205887038 512 dbSNP
rs905254358 513 dbSNP
rs1426811509 514 dbSNP
rs1045270254 517 dbSNP
rs1049679 522 dbSNP
rs1454169890 523 dbSNP
rs915393538 532 dbSNP
rs1053153792 533 dbSNP
rs73611761 536 dbSNP
rs1455069553 538 dbSNP
rs935587429 545 dbSNP
rs759598047 548 dbSNP
rs1383697942 549 dbSNP
rs922267379 550 dbSNP
rs73611760 552 dbSNP
rs1327261702 567 dbSNP
rs976404142 568 dbSNP
rs964150271 570 dbSNP
rs73611759 571 dbSNP
rs1259221627 582 dbSNP
rs1185068827 584 dbSNP
rs774173278 585 dbSNP
rs1260353908 592 dbSNP
rs1482676227 595 dbSNP
rs1211720825 599 dbSNP
rs1233380662 613 dbSNP
rs1253661334 619 dbSNP
rs73611758 622 dbSNP
rs1468447440 624 dbSNP
rs1192284516 632 dbSNP
rs1240455774 633 dbSNP
rs73611757 640 dbSNP
rs1305526283 641 dbSNP
rs752721921 651 dbSNP
rs73611756 655 dbSNP
rs1166502575 662 dbSNP
rs1394510605 664 dbSNP
rs1440138786 665 dbSNP
rs868658306 674 dbSNP
rs6095755 676 dbSNP
rs1375335838 677 dbSNP
rs1391777014 678 dbSNP
rs1025425012 680 dbSNP
rs1235316253 681 dbSNP
rs1337135154 683 dbSNP
rs994499953 689 dbSNP
rs1212438777 690 dbSNP
rs959945210 694 dbSNP
rs1481212921 695 dbSNP
rs80158980 707 dbSNP
rs1176991228 716 dbSNP
rs1374234484 717 dbSNP
rs1189594783 720 dbSNP
rs770370283 720 dbSNP
rs1003516625 725 dbSNP
rs1440716704 726 dbSNP
rs528773295 733 dbSNP
rs73611755 737 dbSNP
rs754594279 740 dbSNP
rs114097793 742 dbSNP
rs894010518 746 dbSNP
rs1162340301 755 dbSNP
rs1370882745 759 dbSNP
rs73611754 761 dbSNP
rs181019888 762 dbSNP
rs1294129970 768 dbSNP
rs1408137007 770 dbSNP
rs59124899 782 dbSNP
rs73611753 784 dbSNP
rs1231543169 786 dbSNP
rs1275125492 791 dbSNP
rs1308627808 793 dbSNP
rs1204375556 796 dbSNP
rs1250024552 804 dbSNP
rs1456351686 814 dbSNP
rs1237495207 815 dbSNP
rs1486838574 816 dbSNP
rs1214022611 818 dbSNP
rs1257803242 820 dbSNP
rs935583318 830 dbSNP
rs1271508513 837 dbSNP
rs1244392235 841 dbSNP
rs1317572762 849 dbSNP
rs374126556 852 dbSNP
rs545495098 853 dbSNP
rs1169620042 856 dbSNP
rs1352615743 859 dbSNP
rs1436338365 859 dbSNP
rs1313200964 861 dbSNP
rs1375075469 863 dbSNP
rs751129605 864 dbSNP
rs1413119490 874 dbSNP
rs1272020927 875 dbSNP
rs1041683241 878 dbSNP
rs578177787 886 dbSNP
rs1376727045 888 dbSNP
rs777590807 892 dbSNP
rs558706247 895 dbSNP
rs942395810 897 dbSNP
rs1280016716 904 dbSNP
rs1392791136 909 dbSNP
rs1361971820 912 dbSNP
rs1243387885 918 dbSNP
rs1485907657 920 dbSNP
rs1185916313 925 dbSNP
rs1388262194 926 dbSNP
rs1455480410 928 dbSNP
rs1174063318 940 dbSNP
rs1394193833 946 dbSNP
rs910887394 954 dbSNP
rs1320495288 955 dbSNP
rs1345930033 957 dbSNP
rs1430124432 962 dbSNP
rs1287125744 968 dbSNP
rs983869694 971 dbSNP
rs1291407801 973 dbSNP
rs1303193371 981 dbSNP
rs1346130710 983 dbSNP
rs1457052224 986 dbSNP
rs952432084 989 dbSNP
rs73611752 990 dbSNP
rs755701683 996 dbSNP
rs1317077628 1012 dbSNP
rs879458095 1019 dbSNP
rs1469784005 1021 dbSNP
rs1437288446 1022 dbSNP
rs540060498 1023 dbSNP
rs1160571546 1025 dbSNP
rs573044579 1033 dbSNP
rs1408994300 1041 dbSNP
rs1400303487 1044 dbSNP
rs1157068231 1047 dbSNP
rs1396766423 1056 dbSNP
rs1442334469 1063 dbSNP
rs1325821177 1068 dbSNP
rs1369319531 1073 dbSNP
rs190672140 1074 dbSNP
rs1444828879 1076 dbSNP
rs1280434152 1082 dbSNP
rs1373645674 1091 dbSNP
rs972570791 1099 dbSNP
rs1194262082 1117 dbSNP
rs765923024 1130 dbSNP
rs1265745096 1133 dbSNP
rs1455399165 1136 dbSNP
rs762699970 1141 dbSNP
rs1265068992 1146 dbSNP
rs1209049303 1147 dbSNP
rs535813598 1151 dbSNP
rs1233198266 1158 dbSNP
rs960241899 1164 dbSNP
rs1180249701 1188 dbSNP
rs568498428 1197 dbSNP
rs1486294844 1198 dbSNP
rs1164232469 1203 dbSNP
rs556570713 1205 dbSNP
rs1412091779 1207 dbSNP
rs1262719681 1210 dbSNP
rs1329996253 1217 dbSNP
rs980407866 1220 dbSNP
rs1213660633 1225 dbSNP
rs1353150640 1227 dbSNP
rs2733 1233 dbSNP
rs1233380045 1238 dbSNP
rs1292094517 1241 dbSNP
rs535738819 1244 dbSNP
rs1369457027 1245 dbSNP
rs1011001131 1265 dbSNP
rs765686922 1266 dbSNP
rs1031603733 1267 dbSNP
rs1203354214 1273 dbSNP
rs15218 1282 dbSNP
rs115164526 1285 dbSNP
rs1290320039 1286 dbSNP
rs1475619019 1289 dbSNP
rs901321066 1293 dbSNP
rs73611751 1295 dbSNP
rs1476701953 1299 dbSNP
rs1168962884 1306 dbSNP
rs368384878 1309 dbSNP
rs186621934 1313 dbSNP
rs1376935527 1315 dbSNP
rs762056905 1317 dbSNP
rs1436456382 1320 dbSNP
rs1332988963 1321 dbSNP
rs777176288 1322 dbSNP
rs942949266 1323 dbSNP
rs1270685435 1324 dbSNP
rs1363373433 1335 dbSNP
rs374324590 1337 dbSNP
rs1428912944 1341 dbSNP
rs1225910254 1354 dbSNP
rs1282143095 1355 dbSNP
rs1486133858 1362 dbSNP
rs1210412389 1366 dbSNP
rs1254217844 1375 dbSNP
rs889457438 1375 dbSNP
rs1191826713 1381 dbSNP
rs1487990461 1385 dbSNP
rs1373022045 1398 dbSNP
rs1448129799 1401 dbSNP
rs1281066370 1405 dbSNP
rs1213149742 1406 dbSNP
rs35338409 1406 dbSNP
rs1343402798 1408 dbSNP
rs1255931478 1409 dbSNP
rs1399513469 1410 dbSNP
rs1048011735 1411 dbSNP
rs931083930 1412 dbSNP
rs201099481 1421 dbSNP
rs1271986371 1422 dbSNP
rs1353042650 1422 dbSNP
rs1432746752 1422 dbSNP
rs566510389 1422 dbSNP
rs74435910 1422 dbSNP
rs878876092 1422 dbSNP
rs1328625645 1423 dbSNP
rs1205794427 1424 dbSNP
rs972879830 1424 dbSNP
rs1297242339 1427 dbSNP
rs752330982 1427 dbSNP
rs1397809291 1428 dbSNP
rs1339472928 1430 dbSNP
rs1174333184 1434 dbSNP
rs1312916426 1434 dbSNP
rs1375579599 1442 dbSNP
rs2664563 1444 dbSNP
rs1454988695 1452 dbSNP
rs938551200 1460 dbSNP
rs1387243547 1463 dbSNP
rs1455608963 1484 dbSNP
rs1327830454 1490 dbSNP
rs1371532175 1495 dbSNP
rs1386020825 1504 dbSNP
rs1298832061 1509 dbSNP
rs1240003244 1512 dbSNP
rs1337784130 1512 dbSNP
rs1049871 1514 dbSNP
rs1327157604 1518 dbSNP
rs1216160245 1521 dbSNP
rs2664532 1524 dbSNP
rs1274370806 1536 dbSNP
rs1208925504 1542 dbSNP
rs1189876483 1543 dbSNP
rs1253044829 1555 dbSNP
rs1420551660 1557 dbSNP
rs1171986317 1558 dbSNP
rs1182039828 1561 dbSNP
rs1462301497 1567 dbSNP
rs980050190 1569 dbSNP
rs1395129720 1571 dbSNP
rs1457306679 1576 dbSNP
rs1291620766 1579 dbSNP
rs1398328634 1584 dbSNP
rs761101085 1590 dbSNP
rs969926367 1594 dbSNP
rs1374631996 1600 dbSNP
rs1168298684 1612 dbSNP
rs567922169 1613 dbSNP
rs1258489626 1614 dbSNP
rs989456149 1616 dbSNP
rs1190084659 1617 dbSNP
rs1235224359 1618 dbSNP
rs1293945527 1626 dbSNP
rs10567504 1627 dbSNP
rs1219973741 1627 dbSNP
rs1253488306 1627 dbSNP
rs1322759081 1629 dbSNP
rs1481160284 1630 dbSNP
rs1205497350 1632 dbSNP
rs201015788 1632 dbSNP
rs1044975480 1633 dbSNP
rs1189482605 1637 dbSNP
rs775575773 1639 dbSNP
rs754458946 1645 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection ...

- Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' agaugagguuuuccgaUGUUAGu 5'
                          |||||| 
Target 5' -------acacaucacACAAUCa 3'
1 - 16
Article - Hafner M; Landthaler M; Burger L; Khorshid et al.
- Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
Experimental Support 2 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Disease 387522.0
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... "PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1 ...

- Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods.

Article - Kishore S; Jaskiewicz L; Burger L; Hausser et al.
- Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
Experimental Support 3 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Disease 387522.0
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... "PAR-CLIP data was present in GSM1065668. RNA binding protein: AGO1. Condition:4-thiouridine "PAR-CLIP data was present in GSM1065669. RNA binding protein: AGO1. Condition:4-thiouridine "PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine ...

- Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature.

Article - Memczak S; Jens M; Elefsinioti A; Torti F; et al.
- Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
Experimental Support 4 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462573. RNA binding protein: AGO2. Condition:TZM-bl BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
Experimental Support 5 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HCT116
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in ERX177606. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_8 ...

- Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research.

Article - Krell J; Stebbing J; Carissimi C; Dabrowska et al.
- Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
Experimental Support 6 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions Prostate Tissue
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in SRX1760597. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_C ...

- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.).

Article - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al.
- Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
CLIP-seq Support 1 for dataset GSM4903825
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / PID14_NS
Location of target site NM_199203 | 3UTR | AACUGUGAAAAGACACAUCACACAAUCACCUUGCUGCUGAUUACACGGCCUGGGGUCUCUGCCUUCUCCCCUUACCCUCCCGCCUCCCACCCUCCCUGCAACAACAGCCCUCUAGCCUGGGGGGCUUGUUAGAGUAGAUGUGAAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161237
CLIP-seq Viewer Link
CLIP-seq Support 2 for dataset GSM4903833
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / CTL_TD_21_a
Location of target site NM_199203 | 3UTR | ACGUAGUUGAACUUCUGGGAUCAAGAAAGUCUAUUUAAAUUGAUUCCCAUCAUAACUGGUGGGGCACAUCUAACUCAACUGUGAAAAGACACAUCACACAAUCACCUUGCUGCUGAUUACACGGCCUGGGGUCUCUGCCUUCUCCCCUUACCCUCCCGCCUCCCACCCUCCCUGCAACAACAGCCCUCUAGCCUGGGGGGCUUGUUAGAGUAGAUGUGAAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 3 for dataset GSM4903835
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / CTL_TD_21_c
Location of target site NM_199203 | 3UTR | CACAAUCACCUUGCUGCUGAUUACACGGCCUGGGGUCUCUGCCUUCUCCCCUUACCCUCCCGCCUCCCACCCUCCCUGCAACAACAGCCCUCUAGCCUGGGGGGCUUGUUAGAGUAGAUGUGAAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 4 for dataset GSM4903836
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / 124_TD_21_a
Location of target site NM_199203 | 3UTR | CUCAACUGUGAAAAGACACAUCACACAAUCACCUUGCUGCUGAUUACACGGCCUGGGGUCUCUGCCUUCUCCCCUUACCCUCCCGCCUCCCACCCUCCCUGCAACAACAGCCCUCUAGCCUGGGGGGCUUGUUAGAGUAGAUGUGAAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 5 for dataset GSM4903837
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / 124_TD_21_b
Location of target site NM_199203 | 3UTR | CAACUGUGAAAAGACACAUCACACAAUCACCUUGCUGCUGAUUACACGGCCUGGGGUCUCUGCCUUCUCCCCUUACCCUCCCGCCUCCCACCCUCCCUGCAACAACAGCCCUCUAGCCUGGGGGGCUUGUUAGAGUAGAUGUGAAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 6 for dataset GSM4903838
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / 124_TD_21_c
Location of target site NM_199203 | 3UTR | UUAAAUUGAUUCCCAUCAUAACUGGUGGGGCACAUCUAACUCAACUGUGAAAAGACACAUCACACAAUCACCUUGCUGCUGAUUACACGGCCUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 7 for dataset GSM545216
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / miR-124 transfection
Location of target site ENST00000341698.2 | 3UTR | ACACAUCACACAAUCACCUUGCUGCUGA
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 20371350 / GSE21578
CLIP-seq Viewer Link
CLIP-seq Support 8 for dataset GSM545217
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / miR-7 transfection
Location of target site ENST00000341698.2 | 3UTR | ACACAUCACACAAUCACCUUGCUGCUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 20371350 / GSE21578
CLIP-seq Viewer Link
CLIP-seq Support 9 for dataset GSM714645
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / completeT1, repB
Location of target site ENST00000341698.2 | 3UTR | ACACAUCACACAAUCACCUUGCUGCUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 21572407 / GSE28865
CLIP-seq Viewer Link
CLIP-seq Support 10 for dataset GSM1065668
Method / RBP PAR-CLIP / AGO1
Cell line / Condition HEK293 / 4-thiouridine, ML_MM_7
Location of target site ENST00000341698.2 | 3UTR | ACACAUCACACAAUCACCUUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23446348 / GSE43573
CLIP-seq Viewer Link
CLIP-seq Support 11 for dataset GSM1065669
Method / RBP PAR-CLIP / AGO1
Cell line / Condition HEK293 / 4-thiouridine, ML_MM_8
Location of target site ENST00000341698.2 | 3UTR | ACACAUCACACAAUCACCUUGCUGCUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23446348 / GSE43573
CLIP-seq Viewer Link
CLIP-seq Support 12 for dataset GSM1065670
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / 4-thiouridine, 3_ML_LG
Location of target site ENST00000341698.2 | 3UTR | ACACAUCACACAAUCACCUUGCUGCUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23446348 / GSE43573
CLIP-seq Viewer Link
CLIP-seq Support 13 for dataset GSM1462573
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl BaL
Location of target site ENST00000341698.2 | 3UTR | ACACAUCACACAAUCACCUUGCUGCUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
GSE42095 Differentiated embryonic stem cells -0.517 5.8e-3 -0.564 2.5e-3 23 Click to see details
GSE19350 CNS germ cell tumors -0.638 1.3e-2 -0.135 3.4e-1 12 Click to see details
GSE21687 Ependynoma primary tumors -0.214 4.5e-2 -0.224 3.8e-2 64 Click to see details
GSE38226 Liver fibrosis -0.343 6.4e-2 -0.270 1.2e-1 21 Click to see details
GSE28544 Breast cancer 0.293 8.2e-2 0.179 2.0e-1 24 Click to see details
GSE21849 B cell lymphoma 0.233 1.1e-1 0.390 1.8e-2 29 Click to see details
GSE32688 Pancreatic cancer -0.189 1.5e-1 -0.225 1.1e-1 32 Click to see details
GSE14794 Lymphoblastoid cells 0.078 2.3e-1 0.039 3.6e-1 90 Click to see details
GSE27834 Pluripotent stem cells 0.11 3.4e-1 0.159 2.8e-1 16 Click to see details
GSE26953 Aortic valvular endothelial cells -0.069 3.7e-1 -0.094 3.3e-1 24 Click to see details
GSE17306 Multiple myeloma -0.013 4.6e-1 -0.038 4.0e-1 49 Click to see details
GSE28260 Renal cortex and medulla 0.003 5.0e-1 0.379 1.0e-1 13 Click to see details
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
LUSC 0.217 0.1 0.187 0.13 38 Click to see details
BLCA 0.314 0.11 0.333 0.1 17 Click to see details
LUAD -0.368 0.12 -0.107 0.37 12 Click to see details
STAD -0.234 0.12 -0.361 0.04 26 Click to see details
PRAD -0.152 0.16 -0.236 0.06 44 Click to see details
CESC -0.864 0.17 -1.000 0.5 3 Click to see details
KIRC -0.106 0.2 -0.076 0.27 67 Click to see details
PAAD 0.448 0.28 0.350 0.33 4 Click to see details
CHOL 0.268 0.28 0.464 0.15 7 Click to see details
ESCA -0.194 0.28 0.127 0.35 11 Click to see details
HNSC 0.084 0.3 0.112 0.24 41 Click to see details
THCA 0.048 0.36 0.074 0.29 59 Click to see details
COAD 0.15 0.39 0.371 0.23 6 Click to see details
BRCA 0.029 0.4 0.028 0.4 82 Click to see details
KICH 0.014 0.47 0.053 0.4 25 Click to see details
PCPG 0.057 0.48 -0.500 0.33 3 Click to see details
KIRP 0.004 0.49 0.010 0.48 32 Click to see details
UCEC -0.002 0.5 -0.063 0.4 19 Click to see details
LIHC 0.001 0.5 0.171 0.13 47 Click to see details
LIHC 0.001 0.5 0.171 0.13 47 Click to see details
54 hsa-miR-508-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT063876 RASSF8 Ras association domain family member 8 2 6
MIRT066527 HMGA2 high mobility group AT-hook 2 2 6
MIRT068025 PUM1 pumilio RNA binding family member 1 2 4
MIRT098837 PCMT1 protein-L-isoaspartate (D-aspartate) O-methyltransferase 2 2
MIRT178933 C11ORF57 chromosome 11 open reading frame 57 2 2
MIRT204599 HSPE1-MOB4 HSPE1-MOB4 readthrough 2 8
MIRT204630 MOB4 MOB family member 4, phocein 2 8
MIRT210911 NFKB1 nuclear factor kappa B subunit 1 4 1
MIRT305650 MBNL1 muscleblind like splicing regulator 1 2 2
MIRT443975 SSH2 slingshot protein phosphatase 2 2 2
MIRT454715 UBQLNL ubiquilin like 2 2
MIRT459224 MRPS21 mitochondrial ribosomal protein S21 2 2
MIRT466978 STARD7 StAR related lipid transfer domain containing 7 2 4
MIRT467402 SOCS3 suppressor of cytokine signaling 3 2 2
MIRT467974 SKIL SKI like proto-oncogene 2 4
MIRT470408 PPP1R15B protein phosphatase 1 regulatory subunit 15B 2 2
MIRT473417 MDM4 MDM4, p53 regulator 2 2
MIRT475302 IFNLR1 interferon lambda receptor 1 2 2
MIRT477176 F3 coagulation factor III, tissue factor 2 8
MIRT479210 CLCC1 chloride channel CLIC like 1 2 2
MIRT481469 ARPP19 cAMP regulated phosphoprotein 19 2 4
MIRT484001 ATAD5 ATPase family, AAA domain containing 5 2 10
MIRT484985 UBE2V1 ubiquitin conjugating enzyme E2 V1 2 8
MIRT485022 TMEM189-UBE2V1 TMEM189-UBE2V1 readthrough 2 8
MIRT485041 TMEM189 transmembrane protein 189 2 8
MIRT498614 MTRNR2L10 MT-RNR2-like 10 2 6
MIRT503751 CEP19 centrosomal protein 19 2 6
MIRT505081 ZBTB18 zinc finger and BTB domain containing 18 2 4
MIRT505653 SHMT1 serine hydroxymethyltransferase 1 2 4
MIRT507081 GXYLT1 glucoside xylosyltransferase 1 2 6
MIRT509374 FGD6 FYVE, RhoGEF and PH domain containing 6 2 4
MIRT509723 EFCAB11 EF-hand calcium binding domain 11 2 4
MIRT524432 CNKSR3 CNKSR family member 3 2 2
MIRT528250 BMS1 BMS1, ribosome biogenesis factor 2 2
MIRT537067 GPR176 G protein-coupled receptor 176 2 2
MIRT538668 CCSAP centriole, cilia and spindle associated protein 2 2
MIRT540931 OIP5 Opa interacting protein 5 2 2
MIRT541405 CBX4 chromobox 4 2 2
MIRT544753 C8orf33 chromosome 8 open reading frame 33 2 2
MIRT552421 ZNF460 zinc finger protein 460 2 2
MIRT554647 ROBO1 roundabout guidance receptor 1 2 2
MIRT563243 QRFPR pyroglutamylated RFamide peptide receptor 2 2
MIRT565471 SRSF1 serine and arginine rich splicing factor 1 2 2
MIRT572697 NCMAP non-compact myelin associated protein 2 2
MIRT612110 CHRM3 cholinergic receptor muscarinic 3 2 2
MIRT616197 SATB2 SATB homeobox 2 2 2
MIRT621104 IL36B interleukin 36, beta 2 2
MIRT627778 RAB30 RAB30, member RAS oncogene family 2 2
MIRT654267 RGS17 regulator of G protein signaling 17 2 2
MIRT691432 PRICKLE4 prickle planar cell polarity protein 4 2 2
MIRT691693 FLOT2 flotillin 2 2 2
MIRT735916 NR4A3 nuclear receptor subfamily 4 group A member 3 3 0
MIRT737419 PCAT1 prostate cancer associated transcript 1 (non-protein coding) 3 0
MIRT755553 GSPT1 G1 to S phase transition 1 3 1
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-508-3p Glucose NULL 5793 Quantitative real-time PCR endothelial cells 24394957 2014 down-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-508 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-508 Androstenedione+Letrozole resistant cell line (MCF-7)
hsa-mir-508 Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-miR-508-3p (-)-eburnamonine 71203 NSC322920 sensitive
hsa-miR-508-3p (-)7,8-dihydrocalanolide a 383107 NSC682400 sensitive
hsa-miR-508-3p (1-(((2-amino-6-chloro-4-pyrimidinyl)amino)methyl)-3-isopropylcyclobutyl)methanol 385230 NSC676343 sensitive
hsa-miR-508-3p (1s,4e,8e,12r,13r)-12-hydroxy-4,8,12-trimethyl-16-methylidene-14-oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one 24204797 NSC732954 sensitive
hsa-miR-508-3p (2E)-2-[4-[tert-butyl(dimethyl)silyl]oxy-2-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-ylidene]acetonitrile 5469272 NSC685189 sensitive
hsa-miR-508-3p (2E)-N-[2-[[(6aS)-2-methoxy-11-oxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]ethyl]-2-[(6aS)-2-methoxy-11-oxo-3-phenylmethoxy-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-8-ylidene]acetamide 10032352 NSC728035 sensitive
hsa-miR-508-3p (2e,4e,6z,8e)-n-(1,3-benzodioxol-5-yl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide 24202490 NSC672131 sensitive
hsa-miR-508-3p (3e)-3-[(2,6-dimethylimidazo[2,1-b][1,3]thiazol-5-yl)methylidene]-1h-indol-2-one 5471419 NSC711074 sensitive
hsa-miR-508-3p (3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-4-(4,5-dihydro-1H-imidazol-2-yl)butan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol 391085 NSC689620 sensitive
hsa-miR-508-3p (3s,5s)-4-benzyl-3,5-bis(2-methoxyphenyl)hexahydro-1h-pyrrolizinium chloride 402114 NSC715973 sensitive
hsa-miR-508-3p (3s,8r,9s,10r,13s,14s,16e)-3-hydroxy-10,13-dimethyl-16-[(4-nitrophenyl)methylidene]-2,3,4,7,8,9,11,12,14,15-decahydro-1h-cyclopenta[a]phenanthren-17-one 5472098 NSC716261 resistant
hsa-miR-508-3p (3z,5z)-3,5-bis[(4-methoxyphenyl)methylidene]-1,1-dimethylpiperidin-1-ium-4-one;iodide 54608638 NSC634792 sensitive
hsa-miR-508-3p (4-methoxyphenyl)(2,3,4-trimethoxyphenyl)methanone 240478 NSC46683 sensitive
hsa-miR-508-3p (4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl)methyl 2,2-diphenylacetate 359628 NSC620687 sensitive
hsa-miR-508-3p (4aR,9aR)-9-(4-methylphenyl)sulfonyl-3,4,4a,9a-tetrahydrocarbazole 372866 NSC648556 sensitive
hsa-miR-508-3p (4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-N-[[(7-oxo-2,6-dihydrotriazolo[4,5-d]pyrimidin-5-yl)amino]methyl]-4,4a,5,5a-tetrahydrotetracene-2-carboxamide 135422275 NSC67586 sensitive
hsa-miR-508-3p (4z,5z)-1-[(e)-(2-hydroxyphenyl)methyleneamino]-3-phenyl-4,5-bis(phenylimino)imidazolidine-2-thione 135509182 NSC671409 resistant
hsa-miR-508-3p (5ar,6r,8ar)-6-(1,5-dimethylhexyl)-5a-methyl-2,3,4,5,6,7,8,8a-octahydro-1h-cyclopenta[b]azepine 403828 NSC719362 sensitive
hsa-miR-508-3p (5E)-3-(4-chlorophenyl)-1,1-dioxo-2-phenyl-5-[(3,4,5-trimethoxyphenyl)methylidene]-1,3-thiazolidin-4-one 5470264 NSC699092 sensitive
hsa-miR-508-3p (5E)-3-(4-chlorophenyl)-2-phenyl-5-[(3,4,5-trimethoxyphenyl)methylidene]-1,3-thiazolidin-4-one 5470241 NSC699069 sensitive
hsa-miR-508-3p (5r,5ar,8ar,9s)-9-[(2r,3s)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-chromen-8-yl]-5-(3,4,5-trimethoxyphenyl)-5a,8,8a,9-tetrahydro-5h-[2]benzofuro[6,5-f][1,3]benzodioxol-6-one 397857 NSC706480 sensitive
hsa-miR-508-3p (5r,6s)-5-phenyl-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(14),2,10,12-tetraene-4-carbothioamide 5467466 NSC652809 sensitive
hsa-miR-508-3p (5z)-3-[4-benzoyl-2-[(4z)-5-oxo-2-phenyl-4-[(3,4,5-trimethoxyphenyl)methylidene]imidazol-1-yl]phenyl]-2-phenyl-5-[(3,4,5-trimethoxyphenyl)methylidene]imidazol-4-one NSC711885 sensitive
hsa-miR-508-3p (5z)-5-[(2-chlorophenyl)methylidene]-3-(furan-2-ylmethyl)-2-phenylimidazol-4-one 24204861 NSC733164 sensitive
hsa-miR-508-3p (6-acetamido-5-imino-7-methyl-8-oxo-2,3-dihydro-1h-pyrrolo[1,2-a]benzimidazol-3-yl) 2-methoxyacetate 377193 NSC658420 sensitive
hsa-miR-508-3p (6Z,8R,9S,13S,14S,17S)-2-ethoxy-6-methoxyimino-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthrene-3,17-diol 5469096 NSC683125 sensitive
hsa-miR-508-3p (7-acetamido-2-acetyloxy-1-methoxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-3-yl) acetate 435732 NSC374980 sensitive
hsa-miR-508-3p (7ar)-1,6-bis(4-methoxyphenyl)-7a-phenyltetrahydroimidazo[1,5-b][1,2,4]oxadiazol-2(1h)-one 402882 NSC717189 sensitive
hsa-miR-508-3p (8e)-2-amino-4-(3,4-dimethoxyphenyl)-8-[(3,4-dimethoxyphenyl)methylidene]-5-methyl-6,7-dihydro-5h-quinoline-3-carbonitrile NSC690754 sensitive
hsa-miR-508-3p (8R,9S,13S,14S,16E)-3-hydroxy-13-methyl-16-(pyridin-4-ylmethylidene)-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-17-one 5470644 NSC703823 sensitive
hsa-miR-508-3p (8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-2-(2,2,2-trifluoroethoxy)-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-one 387663 NSC681684 sensitive
hsa-miR-508-3p (e)-1-(3,5-ditert-butyl-4-hydroxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one 5471156 NSC709100 sensitive
hsa-miR-508-3p (E)-1-(7-methoxy-3-methyl-4-oxido-1-oxoquinoxalin-1-ium-2-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 54612660 NSC741738 resistant
hsa-miR-508-3p (E)-1-[3,5-bis[(dimethylamino)methyl]-4-hydroxyphenyl]-3-phenylprop-2-en-1-one 6374691 NSC677784 sensitive
hsa-miR-508-3p (E)-1-[4-(quinazolin-4-ylamino)phenyl]-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one 155816064 NSC760015 sensitive
hsa-miR-508-3p (e)-1-[4-[[4,6-bis(4-fluoroanilino)-1,3,5-triazin-2-yl]amino]phenyl]-3-(4-methoxyphenyl)prop-2-en-1-one 24205905 NSC737224 sensitive
hsa-miR-508-3p (e)-2-methyl-1-[2-(2-methyl-1h-indol-3-yl)indolin-1-yl]but-2-en-1-one 5388204 NSC633484 sensitive
hsa-miR-508-3p (e)-3-(1,3-benzodioxol-5-yl)-1-(3,5-ditert-butyl-4-hydroxyphenyl)prop-2-en-1-one 5471158 NSC709102 sensitive
hsa-miR-508-3p (E)-3-(4-methoxyphenyl)-2-(4-oxo-3H-quinazolin-2-yl)prop-2-enenitrile 135454458 NSC684969 resistant
hsa-miR-508-3p (E)-3-(6-thiophen-2-ylimidazo[2,1-b][1,3]thiazol-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 50908742 NSC750743 sensitive
hsa-miR-508-3p (E)-3-[4-(dimethylamino)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one 5468166 NSC665694 sensitive
hsa-miR-508-3p (E)-but-2-enedioic acid;2-[4-tert-butyl-1-[(4-methylphenyl)methyl]cyclohexyl]oxy-N,N-dimethylethanamine 5351426 NSC670225 sensitive
hsa-miR-508-3p (E)-N-ethyl-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)prop-2-enamide 5388754 NSC638409 sensitive
hsa-miR-508-3p (ne)-n-[(3e,8r,9s,10r,13s,14s,16e)-16-[(3,4-dimethoxyphenyl)methylidene]-3-hydroxyimino-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthren-17-ylidene]hydroxylamine 9572443 NSC716260 sensitive
hsa-miR-508-3p (nz)-n-[1-[4-[(4-imidazol-1-ylquinolin-2-yl)amino]phenyl]ethylidene]hydroxylamine 24204871 NSC733301 sensitive
hsa-miR-508-3p (z)-(5-bromo-2-oxo-1h-indol-3-ylidene)sulfamic acid 135505239 NSC707054 sensitive
hsa-miR-508-3p (Z)-but-2-enedioic acid;4-(dimethylamino)-1-[6-[4-(dimethylamino)butanoyl]-9-ethylcarbazol-3-yl]butan-1-one 6450892 NSC292816 resistant
hsa-miR-508-3p (z)-n-(1,3-benzodioxol-5-ylmethyl)-n-tert-butyl-3-phenylsulfanylprop-2-enamide 5470808 NSC705327 sensitive
hsa-miR-508-3p (z) 3,3',4,5-tetramethoxystilbene 5388774 NSC638492 sensitive
hsa-miR-508-3p [(10R,13S,16E)-16-[[3-methoxy-4-(2-pyrrolidin-1-ylethoxy)phenyl]methylidene]-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate 24203499 NSC728323 sensitive
hsa-miR-508-3p [(1s,2s,3r,4s,7r,9s,10s,12r,15s)-4,12-diacetyloxy-1,9-dihydroxy-15-[(2r,3s)-2-hydroxy-3-(3-methylbutanoylamino)-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]h 6712271 NSC664404 sensitive
hsa-miR-508-3p [(2S,3R,4R,10R,13S,17S)-17-[1-(dimethylamino)ethyl]-4-hydroxy-10,13-dimethyl-3-[[(E)-2-methylbut-2-enoyl]amino]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-yl] acetate 54612848 NSC748900 sensitive
hsa-miR-508-3p [(3bR,9aS,11aS)-2-(2-hydroxy-5-oxo-2H-furan-3-yl)-3b,6,6,9a-tetramethyl-2,3,3a,4,5,5a,7,8,9,9b,10,11-dodecahydronaphtho[2,1-e][1]benzofuran-11a-yl]methyl acetate 378635 NSC661428 sensitive
hsa-miR-508-3p [(3S,10R,13S,16E)-16-[[4-[2-(diethylamino)ethoxy]-3-methoxyphenyl]methylidene]-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate 24203181 NSC727087 sensitive
hsa-miR-508-3p [(3s,8r,9s,10r,13s,14s,16e)-16-(1-acetyloxy-2,2,2-trifluoroethylidene)-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1h-cyclopenta[a]phenanthren-3-yl] acetate 5351782 NSC45238 sensitive
hsa-miR-508-3p [(3S,8R,9S,10R,13S,14S,16E,17S)-17-acetyloxy-16-[[3-methoxy-4-(2-piperidin-1-ylethoxy)phenyl]methylidene]-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate 24204032 NSC730473 sensitive
hsa-miR-508-3p [(8R,9S,13S,14S)-2-ethoxy-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] [(8S,9R,13R,14R)-2-ethoxy-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] sulfite;ethyl acetate 389907 NSC686560 sensitive
hsa-miR-508-3p [(8S,11S,13S,17S)-3,17-dihydroxy-7,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-11-yl] nitrate 380841 NSC666571 sensitive
hsa-miR-508-3p [(9e,21z)-28-(1,3-dithiolan-2-yl)-2,29,31-trihydroxy-11-methoxy-3,7,12,14,17,17,20,24,32-nonamethyl-6,25-dioxo-8,16,18,33-tetraoxa-26-azapentacyclo[25.3.1.14,7.115,19.05,30]tritriaconta-1(30),2,4,9,21 54610764 NSC244404 sensitive
hsa-miR-508-3p [(E)-(1-chloro-2-methylpropylidene)amino] N-anilinocarbamate 5494354 NSC682841 sensitive
hsa-miR-508-3p [2-(4-methoxyphenyl)-2-oxoethyl] (2R)-2-[(4-bromo-2-fluorobenzoyl)amino]-3-[[(2R)-2-[(4-bromo-2-fluorobenzoyl)amino]-3-[2-(4-methoxyphenyl)-2-oxoethoxy]-3-oxopropyl]diselanyl]propanoate 45029327 NSC746149 resistant
hsa-miR-508-3p [3-(bromomethyl)phenyl]methyl-triphenylphosphanium 494045 NSC81280 sensitive
hsa-miR-508-3p [3-[5-[3,5-dihydroxy-4-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl] (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-[4,5-dihydroxy-6-(hydroxymethyl)-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2 385522 NSC676773 sensitive
hsa-miR-508-3p [3-methoxy-2-[methyl(octadecyl)amino]propyl] 2-(trimethylazaniumyl)ethyl phosphate 131966 NSC643826 resistant
hsa-miR-508-3p [3,4,5-triacetyloxy-6-(1-cyano-2-sulfanylidene-4-thiophen-2-yl-5,6-dihydrobenzo[f]isoquinolin-3-yl)oxan-2-yl]methyl acetate 386291 NSC678049 sensitive
hsa-miR-508-3p [4-[[2-(1h-indol-2-yl)-1,3-dioxolan-2-yl]methyl]-1-piperidyl]-phenyl-methanone 398268 NSC707982 sensitive
hsa-miR-508-3p [4-amino-2-[(4-chlorophenyl)amino]thiazol-5-yl]-(4-methoxyphenyl)methanone 399621 NSC710530 sensitive
hsa-miR-508-3p [5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl [5-[5-fluoro-4-(octadecylamino)-2-oxopyrimidin-1-yl]-3-hydroxyoxolan-2-yl]methyl hydrogen phosphate 394835 NSC698687 resistant
hsa-miR-508-3p 1-(1-naphthylmethylene)-4-(1-naphthyl)semicarbazide 5859414 NSC680931 sensitive
hsa-miR-508-3p 1-(2-(2,5-dimethoxyphenyl)ethyl)-4,5-dimethoxy-2-methylbenzene 371216 NSC645265 sensitive
hsa-miR-508-3p 1-(2-naphthylmethyl)-4-[1-(2-naphthylmethyl)-4-piperidyl]piperidine hydrochloride 393913 NSC696885 sensitive
hsa-miR-508-3p 1-(3-bromophenyl)-7-methoxy-3,9-dihydro[1,3]thiazolo[4,3-b]quinazoline 400620 NSC712742 sensitive
hsa-miR-508-3p 1-(3-methoxyphenyl)-4-phenyl-[1,2,4]triazolo[4,3-a]quinoxaline 399100 NSC709516 sensitive
hsa-miR-508-3p 1-(4-chloronaphthalen-1-yl)-2-(dimethylamino)ethanol 4-methylbenzenesulfonate(1:1) 230791 NSC26074 sensitive
hsa-miR-508-3p 1-(6-bromo-2-chloroquinolin-3-yl)-n-(4-chlorophenyl)methanimine 402198 NSC716089 sensitive
hsa-miR-508-3p 1-(9-methoxy-11,12-dihydro-6h-indolo[1,2-b][2]benzazepin-13-yl)ethanone 365697 NSC633551 sensitive
hsa-miR-508-3p 1-(acetyloxy)-2-(2-(1-(acetyloxy)-1h-benzimidazol-2-yl)phenyl)-1h-benzimidazole 355531 NSC609356 sensitive
hsa-miR-508-3p 1-(naphthalen-1-ylmethyl)-4-[1-(naphthalen-1-ylmethyl)piperidin-4-yl]piperidine 364095 NSC669995 sensitive
hsa-miR-508-3p 1-[(4-fluorophenyl)amino]-2,3-propanopyrido[1,2-a]benzimidazole-4-carbonitrile 395404 NSC699940 resistant
hsa-miR-508-3p 1-[(e)-1,3-benzodioxol-5-ylmethylideneamino]-3-(2-chlorophenyl)urea 9572409 NSC715192 sensitive
hsa-miR-508-3p 1-[10-[4-(dimethylamino)-2-methylquinolin-1-ium-1-yl]decyl]-N,N,2-trimethylquinolin-1-ium-4-amine;perchlorate 387883 NSC682095 sensitive
hsa-miR-508-3p 1-[4-[5,6-bis(4-chlorophenyl)-1,2,4-triazin-3-yl]piperazin-1-yl]-2-[4-(4-methoxyphenyl)piperazin-1-yl]ethanone 54613007 NSC749152 sensitive
hsa-miR-508-3p 1-[4-chloro-3-(trifluoromethyl)phenyl]-2-[4-[2-[di(propan-2-yl)amino]ethylamino]-6-methylpyrimidin-2-yl]guanidine 49791547 NSC127328 sensitive
hsa-miR-508-3p 1-[5-[[[4-chlorobutyl(methyl)amino]-[(5-nitrofuran-2-yl)methoxy]phosphoryl]oxymethyl]-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione 404846 NSC721390 sensitive
hsa-miR-508-3p 1-[6-[[tert-butyl(dimethyl)silyl]oxymethyl]-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-5-hex-1-ynyl-6-iodopyrimidine-2,4-dione 45028649 NSC743556 sensitive
hsa-miR-508-3p 1-benzyl-2-methyl-1-(2-phenylethyl)-4,5-dihydroimidazol-1-ium 413544 NSC49460 sensitive
hsa-miR-508-3p 1-benzyl-3-hexadecyl-2-methylimidazolium chloride 44219704 NSC745343 sensitive
hsa-miR-508-3p 1-butoxy-4-(dichloromethylidene)-3,5-dimethyl-1,4-dihydrophosphinine 1-oxide 372646 NSC648100 sensitive
hsa-miR-508-3p 10,14-dimethyl-1,3,12,14-tetraza-10-azoniapentacyclo[11.7.0.03,11.04,9.015,20]icosa-4,6,8,10,12,15,17,19-octaene;iodide 404657 NSC721082 sensitive
hsa-miR-508-3p 11-(3-methoxyphenyl)-2,12,15-triazapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1,3,5,7,9,11,13(21),14(19),15,17-decaen-20-one 54608964 NSC697747 sensitive
hsa-miR-508-3p 13-methoxy-6-methyl-2-nitro-6,9,17-triazatetracyclo[8.7.1.05,18.011,16]octadeca-1,3,5(18),10,12,14,16-heptaene 438699 NSC658995 resistant
hsa-miR-508-3p 17-(3,4-dimethoxyphenyl)-11-(2-hydroxyethyl)-4,7,14-trioxa-11-azatetracyclo[8.7.0.03,8.012,16]heptadeca-1,3(8),9,12(16)-tetraen-15-one 50900826 NSC750721 sensitive
hsa-miR-508-3p 17-methyl-13,14,17-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-1(10),2,4,6,8,11(16),14-heptaen-12-one 403909 NSC719502 resistant
hsa-miR-508-3p 1h-benzimidazole, 5,5'-dithiobis[2-(trifluoromethyl)- (9ci) NSC659162 sensitive
hsa-miR-508-3p 1h-purine, 6-[(1-methyl-4-nitro-1h-imidazol-5-yl)seleno]- 3879067 NSC252628 sensitive
hsa-miR-508-3p 2',6'-dibromo-2-(methoxymethyl)spiro[7,8-dihydro-6h-thieno[3,2-g]quinoline-5,4'-cyclohexa-2,5-diene]-1',4,9-trione 375900 NSC656211 sensitive
hsa-miR-508-3p 2',6'-dibromospiro[7,8-dihydro-6h-pyrido[2,3-g]quinoline-9,4'-cyclohexa-2,5-diene]-1',5,10-trione 383051 NSC671095 sensitive
hsa-miR-508-3p 2-(1-(4-(2-(2-hydroxyethoxy)ethyl)piperazino))naphthazarin NSC658143 sensitive
hsa-miR-508-3p 2-(1-naphthyl)-5,7-dimethyl-1,8-naphthyridin-4(1h)-one 5468781 NSC676184 sensitive
hsa-miR-508-3p 2-(1-propynyl)-3,17.beta.-estradiol 388008 NSC682429 sensitive
hsa-miR-508-3p 2-(1h-benzimidazol-2-yl)-3,4,5,6-tetrachlorobenzohydrazide 402423 NSC716354 sensitive
hsa-miR-508-3p 2-(2-(dimethylamino)ethylamino)naphthazarin 376950 NSC658145 sensitive
hsa-miR-508-3p 2-(2-amino-5-chloro-6-phenylpyrimidin-4-yl)-4-chlorophenol 359847 NSC621457 resistant
hsa-miR-508-3p 2-(2-naphthyl)-5,7-dimethyl-1,8-naphthyridin-4(1h)-one 5468909 NSC679021 sensitive
hsa-miR-508-3p 2-(2,1,3-benzothiadiazol-4-ylsulfonyl)-1-(4-chlorophenyl)guanidine 9572213 NSC707404 sensitive
hsa-miR-508-3p 2-(3-chlorophenyl)-4-phenyl-5,7-dihydropyrido[3,2-d][1]benzazepin-6-one 389012 NSC684480 resistant
hsa-miR-508-3p 2-(3-chlorophenyl)-4-phenyl-5,7-dihydropyrido[3,2-d][1]benzazepine-6-thione 4998423 NSC684481 resistant
hsa-miR-508-3p 2-(3-methylbutylsulfanyl)naphthalene-1,4-dione 315743 NSC241494 sensitive
hsa-miR-508-3p 2-(3-phenyl-4,5-bis(phenylimino)-1,3-thiazolidin-2-ylidene)malononitrile 383253 NSC671367 sensitive
hsa-miR-508-3p 2-(4-chlorophenoxy)-1-[5-hydroxy-3-(5-nitrofuran-2-yl)-5-phenyl-4,5-dihydro-1h-pyrazol-1-yl]ethanone 367872 NSC638038 sensitive
hsa-miR-508-3p 2-(4-chlorophenyl)-1-methylene-3-phenyl-pyrazino[1,2-a]benzimidazole 390230 NSC687522 resistant
hsa-miR-508-3p 2-(4-isothiocyanatophenyl)sulfanylacetic acid 345648 NSC403376 sensitive
hsa-miR-508-3p 2-(4-methylphenyl)-5-(2-naphthyl)-1,3,4-oxadiazole 260000 NSC90810 sensitive
hsa-miR-508-3p 2-(5-chloro-2-methylanilino)-6-(trifluoromethyl)pyridine-3-carboxamide 24204601 NSC732287 resistant
hsa-miR-508-3p 2-(6-benzoyl-1h-benzimidazol-2-yl)-3,4,5,6-tetrachloro-n-(furan-2-yl)benzamide 402231 NSC716122 sensitive
hsa-miR-508-3p 2-(6-bromo-2-chloroquinolin-3-yl)-2-[(4-methoxyphenyl)amino]acetamide 402332 NSC716223 sensitive
hsa-miR-508-3p 2-(ethoxymethyl)-4,7-dimethoxy-6-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-benzimidazole 398957 NSC709341 sensitive
hsa-miR-508-3p 2-(hydroxymethyl)-5-[6-[(2Z)-2-(pyridin-2-ylmethylidene)hydrazinyl]purin-9-yl]oxolane-3,4-diol 60147746 NSC752331 resistant
hsa-miR-508-3p 2-(naphthalen-2-ylamino)-1,2-diphenylethanone 411561 NSC34924 sensitive
hsa-miR-508-3p 2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline 24203444 NSC728037 sensitive
hsa-miR-508-3p 2-[(9-amino-5-methylacridine-4-carbonyl)amino]ethyl-dimethyl-[(2-morpholin-4-yl-4-nitro-1,3-thiazol-5-yl)methyl]azanium;chloride 391709 NSC691251 resistant
hsa-miR-508-3p 2-[(9-amino-5-methylacridine-4-carbonyl)amino]ethyl-dimethyl-[(3-nitrothiophen-2-yl)methyl]azanium;chloride 391705 NSC691249 resistant
hsa-miR-508-3p 2-[[(2-aminobenzoyl)oxy-dibutyl-stannyl]amino]benzoic acid 16684416 NSC628572 sensitive
hsa-miR-508-3p 2-[[(z)-2-benzamido-3-(2-hydroxyphenyl)prop-2-enoyl]amino]-n-(3-hydroxypropyl)benzamide 6477546 NSC686425 resistant
hsa-miR-508-3p 2-[[4-anilino-5-[8-[4-anilino-5-[(1-hydroxynaphthalen-2-yl)oxymethyl]-1,2,4-triazol-3-yl]octyl]-1,2,4-triazol-3-yl]methoxy]naphthalen-1-ol 394049 NSC697167 sensitive
hsa-miR-508-3p 2-[[4,5-bis(4-methoxyphenyl)-1h-imidazol-2-yl]sulfanyl]-n-[(e)-(4-nitrophenyl)methylideneamino]acetamide 9572297 NSC710441 sensitive
hsa-miR-508-3p 2-[[6-[[bis(carboxymethyl)amino]methyl]-4-[2-[4-(2-phenylethynyl)phenyl]ethynyl]pyridin-2-yl]methyl-(carboxymethyl)amino]acetic acid 369524 NSC641379 resistant
hsa-miR-508-3p 2-[[amino-[bis(2-bromoethyl)amino]phosphoryl]oxymethyl]-5-methoxy-1-methylindole-4,7-dione 404935 NSC721513 resistant
hsa-miR-508-3p 2-[[amino-[bis(2-bromoethyl)amino]phosphoryl]oxymethyl]naphthalene-1,4-dione 390536 NSC688023 sensitive
hsa-miR-508-3p 2-[2-[(E)-benzylideneamino]-6-phenylpyrimidin-4-yl]-4-chlorophenol 135509207 NSC678883 resistant
hsa-miR-508-3p 2-[2-hydroxyethyl-[3-[(2-methoxy-6-nitroacridin-9-yl)amino]propyl]amino]ethanol 384257 NSC673803 sensitive
hsa-miR-508-3p 2-[5-(2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyl-1,3-dioxolan-4-yl]-6-methoxy-3-nitro-2H-chromene 358300 NSC618261 sensitive
hsa-miR-508-3p 2-[5-[4-[5-[4-(6-morpholin-4-yl-1H-benzimidazol-2-yl)phenoxy]pentyl]piperazin-1-yl]pentyl]benzo[de]isoquinoline-1,3-dione 44219118 NSC743432 sensitive
hsa-miR-508-3p 2-[6-[(4-hydroxy-3-methoxyphenyl)methylamino]hexyl]benzo[de]isoquinoline-1,3-dione;4-methylbenzenesulfonic acid 60147760 NSC752365 sensitive
hsa-miR-508-3p 2-acetamido-6-methyl-8-hydroxy-1,4-naphthaquinone 377214 NSC658450 sensitive
hsa-miR-508-3p 2-acetyl-1,2-dihydroellipticine 376328 NSC657149 resistant
hsa-miR-508-3p 2-amino-1-N,9-N-bis[10-(1-hydroxyethyl)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3-propan-2-yl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboxamide 383042 NSC671033 sensitive
hsa-miR-508-3p 2-amino-4-(3-methoxyphenyl)-10-methyl-7,7-dioxo-5,6-dihydro-[1]benzothiepino[4,5-c]pyridine-1-carbonitrile 391896 NSC691577 sensitive
hsa-miR-508-3p 2-amino-4-[(2e)-2-[(2,6-dichlorophenyl)methylidene]hydrazinyl]-6-morpholin-4-ylpyrimidine-5-carbonitrile 24204821 NSC733008 sensitive
hsa-miR-508-3p 2-amino-5-[[3-[2-[[5-(4-amino-2-oxopyrimidin-1-yl)-4,4-difluoro-3-hydroxyoxolan-2-yl]methoxy-[4-chlorobutyl(methyl)amino]phosphoryl]oxyethylsulfonyl]-1-[[carboxy(phenyl)methyl]amino]-1-oxopropan-2-yl] 45027980 NSC740475 resistant
hsa-miR-508-3p 2-amino-n-[4,5-dichloro-2-[[methyl-[(1s,2s)-2-pyrrolidin-1-ylcyclohexyl]amino]methyl]phenyl]acetamide 398349 NSC708073 sensitive
hsa-miR-508-3p 2-cyclohepta[b]pyrrol-2-yl-5-methyl-1,2-dihydro-3h-pyrazol-3-one 363757 NSC628949 sensitive
hsa-miR-508-3p 2-imino-1,3-diphenyl-5-phenyliminoimidazolidine-4-thione 383285 NSC671399 sensitive
hsa-miR-508-3p 2-isopropyl-11-oxo-n-[2-(4-phenylpiperazin-1-yl)ethyl]-11h-pyrido[2,1-b]quinazoline-8-carboxamide 353192 NSC600684 sensitive
hsa-miR-508-3p 2-isoquinolin-2-ium-2-yl-1-phenanthren-3-ylethanone;iodide 5351160 NSC35489 sensitive
hsa-miR-508-3p 2-methoxy-4-(3,4,5-trimethoxybenzyl)phenol 368064 NSC638388 sensitive
hsa-miR-508-3p 2-methyl-1-[10-[(2-methylquinolin-4-yl)amino]decyl]quinolin-1-ium-4-amine;chloride;hydrochloride 387885 NSC682096 sensitive
hsa-miR-508-3p 2-methyl-4-(4-morpholin-4-ylphenyl)iminobenzo[f][1,3]benzoxazol-9-one 386916 NSC679822 sensitive
hsa-miR-508-3p 2-n-[3-(diethylaminomethyl)-4-methoxyphenyl]-4-n-[4-(dimethylamino)cyclohexyl]quinazoline-2,4-diamine;hydrochloride 54610390 NSC174030 sensitive
hsa-miR-508-3p 2-naphthalen-2-yl-1h-[1,8]naphthyridin-4-one 386569 NSC679017 sensitive
hsa-miR-508-3p 2-phenyl-7-(trifluoromethyl)-3-(3,4,5-trimethoxyphenoxy)quinoxalin-5-amine NSC683069 sensitive
hsa-miR-508-3p 2-phenyl-N-[3-[4-[3-[(2-phenylquinoline-4-carbonyl)amino]propyl]piperazin-1-yl]propyl]quinoline-4-carboxamide;hydrochloride 384385 NSC674092 sensitive
hsa-miR-508-3p 2,2'-spirobi[3,6,7,8-tetrahydro-1H-cyclopenta[g]naphthalene]-5,5'-dione 382634 NSC670283 sensitive
hsa-miR-508-3p 2,2'-spirobi[indane]-5,5'-dicarbaldehyde 382743 NSC670421 sensitive
hsa-miR-508-3p 2,2'(1h,1'h)-spirobi[s-indacen]-1-one, 4'-acetyl-3,3',5,5',6,6',7,7'-octahydro- 382664 NSC670312 sensitive
hsa-miR-508-3p 2,2,2-trifluoro-N-[3-[naphthalen-2-ylmethyl-[4-[naphthalen-2-ylmethyl-[3-[(2,2,2-trifluoroacetyl)amino]propyl]amino]butyl]amino]propyl]acetamide 389638 NSC685981 sensitive
hsa-miR-508-3p 2,3-dibenzoyloxy-4-hydroxy-4-oxobutanoate;(2,5-dimethylphenyl)-(4-methylphenyl)-phenylsulfanium 5351228 NSC116693 sensitive
hsa-miR-508-3p 2,3-dichloro-5,6,7,8-tetrahydronaphthalene-1,4-diol 320303 NSC267319 resistant
hsa-miR-508-3p 2,3,9,10-tetramethoxy-6,8-dihydro-5h-isoquinolino[2,1-b]isoquinoline-8-carbonitrile 397863 NSC706486 sensitive
hsa-miR-508-3p 2,5-bis(1-hydroxyethyl)thieno[3,2-f][1]benzothiole-4,8-dione 391376 NSC690433 sensitive
hsa-miR-508-3p 2,5-dibenzyl-2-undecyloctahydro-1h-pyrrolo[3,4-c]pyridin-2-ium bromide 378731 NSC661832 sensitive
hsa-miR-508-3p 2,5,9,12-tetrathiabicyclo[11.4.0]heptadeca-1(13),14,16-triene-15,16-dicarbonitrile 387185 NSC680721 resistant
hsa-miR-508-3p 2,6-diamino-n-[2-[[4-[2-(2,6-diaminohexanoylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]hexanamide 438922 NSC684438 resistant
hsa-miR-508-3p 2,6-dibromo-9-[4-(4-methylphenoxy)-5-[(4-methylphenoxy)methyl]oxolan-2-yl]purine 388059 NSC682520 resistant
hsa-miR-508-3p 2,6-dimethoxy-4-(7-methyl-6-(1-piperidinyl)-7,8-dihydro-6h-[1,3]dioxolo[4,5-g]chromen-8-yl)phenol 383126 NSC671167 sensitive
hsa-miR-508-3p 2,6,13,17-tetrazaheptacyclo[15.12.0.01,25.03,16.05,14.07,12.018,23]nonacosa-3,5,7,9,11,13,15,18(23)-octaene 378784 NSC661960 sensitive
hsa-miR-508-3p 2,7-bis(1-hydroxyethyl)thieno[2,3-f][1]benzothiole-4,8-dione 388026 NSC682451 sensitive
hsa-miR-508-3p 20-(3-azidopropyl)-16-nitro-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-1(12),2,4(8),9,13(18),14,16-heptaene-11,19-dione 10070686 NSC728979 resistant
hsa-miR-508-3p 296cfo5qf6 386891 NSC679749 sensitive
hsa-miR-508-3p 3-(2-fluoro-2,2-dinitro-ethoxy)propane-1,2-diol 388365 NSC683260 sensitive
hsa-miR-508-3p 3-(3-methoxyphenyl)-2-(3-phenoxyphenyl)-1,3-thiazolidin-4-one 1,1-dioxide 401415 NSC715067 sensitive
hsa-miR-508-3p 3-(4-chlorophenoxy)-4-[4-(2-dimethylaminoethyloxy)phenyl]-7-methoxy-chromen-2-one 395152 NSC699452 sensitive
hsa-miR-508-3p 3-(4-fluorophenyl)-3-(4-acetoxy-2-methylphenyl)phthalide 383342 NSC671456 resistant
hsa-miR-508-3p 3-(4-fluorophenyl)-3-(4-hydroxy-2-methylphenyl)phthalide 387973 NSC682335 resistant
hsa-miR-508-3p 3-(4-fluorophenyl)-4-methyl-8-pyrrolidin-1-yl-8H-thieno[2,3-b]pyrrolizin-4-ium;iodide 388534 NSC683516 sensitive
hsa-miR-508-3p 3-(4-methoxyphenyl)-1-[(e)-2-(2-thienyl)vinyl]pyrazino[1,2-a]benzimidazole 5471218 NSC709480 sensitive
hsa-miR-508-3p 3-(4-methoxyphenyl)-1-methylidene-2-phenylpyrazino[1,2-a]benzimidazole 390235 NSC687527 sensitive
hsa-miR-508-3p 3-(4-methoxyphenyl)-4-methyl-8-pyrrolidin-1-yl-8H-thieno[2,3-b]pyrrolizin-4-ium;iodide 388538 NSC683518 sensitive
hsa-miR-508-3p 3-[(e)-1-(2-hydroxy-4-methoxy-phenyl)ethylideneamino]-1,1-dimethyl-thiourea 135493996 NSC689547 resistant
hsa-miR-508-3p 3-[2-[(3,5-dichlorophenyl)amino]thiazol-4-yl]chromen-2-one 395985 NSC701109 resistant
hsa-miR-508-3p 3-[5-[2-[2-(4,4-dimethyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)ethylamino]pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl]phenol 138631879 NSC761584 sensitive
hsa-miR-508-3p 3-acetyl-3a-chloro-5,11b-dihydroxy-2-methyl-1-(4-methylphenyl)naphtho[2,3-g]indole-6,11-dione 405625 NSC722995 sensitive
hsa-miR-508-3p 3-chloroindolo[2,1-b]quinazoline-6,12-dione 396706 NSC703315 sensitive
hsa-miR-508-3p 3-chloropyrido[1,2-a]benzimidazole-1,4-dicarbonitrile 378325 NSC660334 sensitive
hsa-miR-508-3p 3-methyl-5-[(2,3,4,5,6-pentafluorophenyl)-[2,3,5,6-tetrafluoro-4-[(3-methyl-1,2-oxazol-5-yl)methyl]phenyl]methyl]-1,2-oxazole 380224 NSC665700 sensitive
hsa-miR-508-3p 3-phenacyliden-5-brom-2-indolinon 5351299 NSC294961 resistant
hsa-miR-508-3p 3,19-(4-acetamido)benzylidineandrographolide 54612901 NSC747452 sensitive
hsa-miR-508-3p 3,5-dichloro-N-[4-[3-(4-chloro-3-hydroxyphenyl)-4-pyridin-4-ylpyrazol-1-yl]phenyl]benzamide 56935331 NSC753190 sensitive
hsa-miR-508-3p 3no2-2pyrid-so2-ph 371687 NSC646125 resistant
hsa-miR-508-3p 4-(2-(((6-bromo-1,3-benzodioxol-5-yl)methyl)amino)ethyl)phenol 290548 NSC154572 sensitive
hsa-miR-508-3p 4-(2-azidophenothiazin-10-yl)-N,N-dimethylbutan-1-amine;oxalic acid 385933 NSC677395 sensitive
hsa-miR-508-3p 4-(3h-[1,3]thiazolo[3,4-a]benzimidazol-1-yl)phenyl acetate 384820 NSC675272 sensitive
hsa-miR-508-3p 4-(4-bromophenyl)-2-phenyl-5,7-dihydropyrido[3,2-d][1]benzazepine-6-thione 3939015 NSC684459 resistant
hsa-miR-508-3p 4-(4-butoxyphenyl)-7,7-dimethyl-2-nonylsulfanyl-5-oxo-1,4,6,8-tetrahydroquinoline-3-carbonitrile 398168 NSC707700 resistant
hsa-miR-508-3p 4-(4-chlorophenyl)-1,1-dimethyl-4,5-dihydro-1h,3h-[1,3,5]oxadiazepino[5,6-a]benzimidazole 374204 NSC651694 sensitive
hsa-miR-508-3p 4-(4-chlorophenyl)-N-(2-methoxyphenyl)-3-prop-2-enyl-1,3-thiazol-2-imine;hydrobromide 396119 NSC701666 sensitive
hsa-miR-508-3p 4-(4,7-dimethoxy-1,3-benzodioxol-5-yl)-5-(4-methoxyphenyl)-2H-triazole 73334660 NSC763198 sensitive
hsa-miR-508-3p 4-(dimethylamino)-9-ethyl-16-methyl-4,20-diazapentacyclo[11.7.0.02,6.07,12.014,19]icosa-1(13),14(19),15,17-tetraene-3,5-dione 397883 NSC706739 sensitive
hsa-miR-508-3p 4-[(2Z)-2-[1-amino-3-(methylamino)-1,3-bis(sulfanylidene)propan-2-ylidene]hydrazinyl]-1H-imidazole-5-carboxamide 5466293 NSC684046 sensitive
hsa-miR-508-3p 4-[(4z)-5-oxo-4-[(4-phenoxyphenyl)methylidene]-2-phenylimidazol-1-yl]-n-(1,3-thiazol-2-yl)benzenesulfonamide 5472414 NSC718649 sensitive
hsa-miR-508-3p 4-[(5-methyl-1,2-oxazol-3-yl)amino]naphthalene-1,2-dione 384243 NSC673784 sensitive
hsa-miR-508-3p 4-[(E)-(4-nitrophenyl)methylideneamino]-3-phenyl-1H-1,2,4-triazol-5-one 9571512 NSC675223 resistant
hsa-miR-508-3p 4-[(e)-2-(6-bromo-1-ethylquinolin-1-ium-2-yl)ethenyl]-n,n-bis(2-chloroethyl)aniline;iodide 54600726 NSC640084 sensitive
hsa-miR-508-3p 4-[(r)-[(2s,5r)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl]-(3-methoxyphenyl)methyl]-n-pentan-3-ylbenzamide;hydrochloride 5471112 NSC708822 sensitive
hsa-miR-508-3p 4-[2-[(2Z)-2-[3-ethyl-4-hydroxy-5-(phenyliminomethyl)-1,3-thiazol-2-ylidene]hydrazinyl]-1,3-thiazol-4-yl]benzene-1,2-diol 135462473 NSC658798 sensitive
hsa-miR-508-3p 4-[2-[4-[3-(4-chlorophenyl)-1-methylene-pyrazino[1,2-a]benzimidazol-2-yl]phenoxy]ethyl]morpholine 399072 NSC709483 sensitive
hsa-miR-508-3p 4-[2-[4-[3-(4-methoxyphenyl)-1-methylene-pyrazino[1,2-a]benzimidazol-2-yl]phenoxy]ethyl]morpholine 399071 NSC709482 sensitive
hsa-miR-508-3p 4-[4-(3-methoxyphenyl)piperazin-1-yl]-5H-pyrrolo[3,2-d]pyrimidine 155815900 NSC754824 sensitive
hsa-miR-508-3p 4-acetylspiro[1,3,5,6,7,8-hexahydrocyclopenta[b]naphthalene-2,2'-3,6,7,8-tetrahydro-1h-cyclopenta[g]naphthalene]-5'-one 382750 NSC670428 sensitive
hsa-miR-508-3p 4-methoxy-2-nitronaphtho[2,1-b]furan 100603 NSC329226 sensitive
hsa-miR-508-3p 4-methoxy-2,6-bis[hydroxy(methyl)amino]-1,3,5-triazine 46191705 NSC749909 resistant
hsa-miR-508-3p 4-methyl-1-oxido-1,2,4-benzotriazin-1-ium-3-imine 360889 NSC623599 sensitive
hsa-miR-508-3p 4-methyl-1,1-diphenyl-1,2,3,4-tetrahydrobenzo(h)phosphinolinium hexafluorophosphate 498151 NSC245398 sensitive
hsa-miR-508-3p 4-methyl-n'-[7-methyl-8-(3,4,5-trimethoxyphenyl)-7,8-dihydro-6h-[1,3]dioxolo[4,5-g]chromen-6-yl]benzenesulfonohydrazide 381384 NSC667924 sensitive
hsa-miR-508-3p 4-methylbenzenesulfonate;(E)-1-[4-(1-methylimidazo[1,2-a]pyridin-4-ium-2-yl)phenyl]-N-[4-[(E)-[4-(1-methylimidazo[1,2-a]pyridin-4-ium-2-yl)phenyl]methylideneamino]piperazin-1-yl]methanimine 9574596 NSC370656 sensitive
hsa-miR-508-3p 4-methylsulfanyl-N-[(3,4,5-trimethoxyphenyl)methyl]aniline 373808 NSC650772 sensitive
hsa-miR-508-3p 4-morpholinecarbodithioic acid, antimony complex NSC625498 sensitive
hsa-miR-508-3p 4-n-(7-chloroquinolin-4-yl)-1-n-cyclohexylcyclohexane-1,4-diamine NSC3618 sensitive
hsa-miR-508-3p 4-n-[12-[(5-amino-6-chloropyrimidin-4-yl)amino]dodecyl]-6-chloropyrimidine-4,5-diamine 358989 NSC619196 sensitive
hsa-miR-508-3p 4-thiomorpholinecarbodithioic acid, antimony complex NSC625497 sensitive
hsa-miR-508-3p 4(1h)-quinazolinone, 2,3-dihydro-2-(1-naphthyl)- (8ci) 286701 NSC145669 sensitive
hsa-miR-508-3p 4,4'-[oxybis(4,1-phenylene)]dipyridine 399433 NSC710272 sensitive
hsa-miR-508-3p 4,6,6-trimethyl-4-[(e)-4-phenylsulfanylbut-1-enyl]norpinan-2-one 5469503 NSC689222 sensitive
hsa-miR-508-3p 4b-hydroxy-10,10-dimethoxy-9ah-indeno[1,2-a]inden-9-one 363252 NSC628000 sensitive
hsa-miR-508-3p 5-(phenyldisulfanyl)pentane-1-sulfinic acid 361236 NSC624191 sensitive
hsa-miR-508-3p 5-[2-(3-hydroxy-4-methoxyphenyl)ethynyl]-6-(3,4,5-trimethoxyphenyl)pyran-2-one 45028148 NSC741289 sensitive
hsa-miR-508-3p 5-[2-[3-phenylpropyl(propyl)amino]ethyl]-1,3-dihydrobenzimidazole-2-thione 3005423 NSC699427 sensitive
hsa-miR-508-3p 5-[3-[(7-chloroquinolin-4-yl)amino]phenyl]-3-(3,4,5-trimethoxyphenyl)-3,4-dihydropyrazole-2-carbaldehyde 72374830 NSC762542 sensitive
hsa-miR-508-3p 5-{[2-(cyclobutylcarbonyl)-6-methoxy-1,2,3,4,5,8-hexahydroisoquinolin-1-yl]methyl}-2-methoxyphenol 401790 NSC715520 sensitive
hsa-miR-508-3p 5-benzyl-4-imino-6-methyl-n-phenyl-7h-pyrrolo[2,3-d]pyrimidin-3-amine 135426658 NSC706031 sensitive
hsa-miR-508-3p 5-benzyl-5h-benzo[b]phosphindole 5-oxide 380786 NSC666496 sensitive
hsa-miR-508-3p 5-chroman-6-yl-2-(4-pyridyl)oxazole 380226 NSC665702 sensitive
hsa-miR-508-3p 5-fluoro-2-deoxycytidine 240980 NSC48006 resistant
hsa-miR-508-3p 5-hydroxy-3-phenylpyrano[3,2-c]chromen-2(5h)-one 24205741 NSC736555 sensitive
hsa-miR-508-3p 5,5,6'-trimethyl-3-phenylspiro[1,3-oxazolidine-4,2'-chromene]-2-thione 392265 NSC692406 sensitive
hsa-miR-508-3p 5,6-dimethoxy-n-(2-piperidin-2-ylethyl)quinolin-8-amine;hydroiodide 24182013 NSC13275 sensitive
hsa-miR-508-3p 5,8-quinolinedione, 6-amino-7-bromo- 266923 NSC105808 sensitive
hsa-miR-508-3p 6-(1-benzofuran-2-yl)-4-(4-chlorophenyl)-2-methylsulfanylpyridine-3-carbonitrile 45029032 NSC745287 resistant
hsa-miR-508-3p 6-(2-hydroxyethyl)indeno[1,2-c]isoquinoline-5,11-dione 334474 NSC339705 resistant
hsa-miR-508-3p 6-(4-hydroxy-2-methylphenyl)-2-(4-methylsulfonylphenyl)-4,5-dihydropyridazin-3-one 136233493 NSC762914 sensitive
hsa-miR-508-3p 6-[3-(3-aminopropylamino)propyl]-13-[3-[(2-methoxyphenyl)methylamino]propyl]-6,13-diazatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),2,4(16),8,10-pentaene-5,7,12,14-tetrone 137645384 NSC760979 sensitive
hsa-miR-508-3p 6-[3-(4-aminobutylamino)propyl]-13-[3-[(2-methoxyphenyl)methylamino]propyl]-6,13-diazatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),2,4(16),8,10-pentaene-5,7,12,14-tetrone 137653213 NSC761769 sensitive
hsa-miR-508-3p 6-[3-[4-(3-aminopropoxy)butoxy]propyl]-13-[3-[(2-methoxyphenyl)methylamino]propyl]-6,13-diazatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),2,4(16),8,10-pentaene-5,7,12,14-tetrone 137647086 NSC760980 sensitive
hsa-miR-508-3p 6-[3-[4-(3-aminopropylamino)butylamino]propyl]-13-[3-[(2-methoxyphenyl)methylamino]propyl]-6,13-diazatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),2,4(16),8,10-pentaene-5,7,12,14-tetrone 137655794 NSC757981 sensitive
hsa-miR-508-3p 6-amino-9-methoxyisoindolo[2,1-a]quinoxalin-3-ol 60147951 NSC753218 sensitive
hsa-miR-508-3p 6-chloro-1-(2-nitrophenyl)sulfonyl-3,4-dihydro-2h-quinoline 380120 NSC665522 sensitive
hsa-miR-508-3p 6-chloro-1-[(4-chloro-2-nitrophenyl)sulfonyl]-1,2,3,4-tetrahydroquinoline 380122 NSC665524 sensitive
hsa-miR-508-3p 6-chloro-3-[(Z)-[2-(4-methoxyphenyl)benzimidazol-5-ylidene]methyl]-1H-indol-2-ol 155806854 NSC763703 sensitive
hsa-miR-508-3p 6-chloro-3-imidazo[1,2-a]pyridin-2-ylchromen-2-one 395976 NSC701100 resistant
hsa-miR-508-3p 6-phenyl-6h-indeno[1,2-c]isoquinoline-5,11-dione 334247 NSC338643 resistant
hsa-miR-508-3p 7'-but-3-en-2-yl-7'-(3-phenylmethoxypropyl)spiro[1,3-dioxolane-2,2'-3,4,7a,8,9,10-hexahydro-1h-cyclopenta[i]indolizine]-6'-thione 361486 NSC624523 sensitive
hsa-miR-508-3p 7-[(3-fluorophenyl)methoxy]-9-[(3-fluorophenyl)methyl]-2-[(4-fluorophenyl)methyl]-1-methylpyrido[3,4-b]indol-2-ium 54766740 NSC760181 sensitive
hsa-miR-508-3p 7-benzyl-3-[(e)-3-oxo-3-phenylprop-1-enyl]-16-thia-2,4,5,7-tetrazatetracyclo[7.7.0.02,6.010,15]hexadeca-1(9),3,5,10(15)-tetraen-8-one 45028585 NSC743396 sensitive
hsa-miR-508-3p 7-bromo-2,4,7-triphenyl-6H-benzo[a]quinolizin-5-ium;bromide 386208 NSC677924 sensitive
hsa-miR-508-3p 7-chloro-10,11-dimethoxy-2,8-diazatricyclo[7.3.1.05,13]trideca-1(12),5,7,9(13),10-pentaene-3,4-dione 397794 NSC706232 sensitive
hsa-miR-508-3p 7-chloro-6-(2-morpholin-4-ylethylamino)quinoline-5,8-dione 379078 NSC663285 sensitive
hsa-miR-508-3p 7-chloro-6-n-(2-fluoroethylamino)-5,8-quinolinedione 379079 NSC663286 sensitive
hsa-miR-508-3p 7-chloro-n-[2-[2-[(7-chloro-1-methylbenzo[g]indole-3-carbonyl)amino]ethyl-methylamino]ethyl]-1-methylbenzo[g]indole-3-carboxamide 397209 NSC704618 resistant
hsa-miR-508-3p 7-chlorobenzo[c]quinolizin-11-ium-6-amine;chloride 386892 NSC679795 sensitive
hsa-miR-508-3p 7-epi-3,4-bis-nor-dolastatin 11 396354 NSC702158 sensitive
hsa-miR-508-3p 7,17-dimethoxy-10,14-dithia-3,12-diaza-1-azoniapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),4(9),5,7,11,15(20),16,18-octaene;iodide 404661 NSC721084 sensitive
hsa-miR-508-3p 7alpha-acetoxyroylenane 362048 NSC753734 sensitive
hsa-miR-508-3p 8-(6-fluorohexyl)-3-methyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride 380336 NSC665863 resistant
hsa-miR-508-3p 8-[(4-tert-butylphenoxy)methyl]-1,3-dimethyl-7H-purine-2,6-dione 235292 NSC36525 sensitive
hsa-miR-508-3p 8-aminoquinoline-5,6-dione 279596 NSC130785 sensitive
hsa-miR-508-3p 8-benzyl-1-phenyl-3-oxa-1,8-diazaspiro[4.5]decan-4-one 380263 NSC665741 sensitive
hsa-miR-508-3p 8(5h)-quinolinone, 7-chloro-5-[[4-(diethylamino)-2-methylphenyl]imino]- 363174 NSC627778 sensitive
hsa-miR-508-3p 9-(3-chloro-2-hydroxy-propyl)-1,3-dimethyl-purino[7,8-a]pyrimidine-2,4,8-trione 392199 NSC692332 resistant
hsa-miR-508-3p 9-[2-(2,5-dimethylpyrrol-1-yl)phenyl]-7-hydroxy-5,6-di(propan-2-yloxy)-3-oxa-1-azatricyclo[6.3.1.04,12]dodeca-4,6,8(12),10-tetraen-2-one 389261 NSC685014 sensitive
hsa-miR-508-3p 9-acridinamine, n-(4-ethoxyphenyl)-, monohydrochloride 2788193 NSC165714 sensitive
hsa-miR-508-3p 9-amino-7-(3,4,5-trimethoxyphenyl)-6h-benzo[c]chromene-8,10-dicarbonitrile 399086 NSC709502 resistant
hsa-miR-508-3p 9-amino-N-[2-(2-aminoethylamino)ethyl]-5-methylacridine-4-carboxamide;hydrochloride 392741 NSC693545 resistant
hsa-miR-508-3p 9-amino-N-[3-(2-aminoethylamino)propyl]-5-methylacridine-4-carboxamide;hydrochloride 392737 NSC693543 resistant
hsa-miR-508-3p 9-chloro-2-methylellipticinium acetate, hydrate 10383530 NSC632855 resistant
hsa-miR-508-3p 9-chlorobenzo[c]quinolizin-11-ium-6-amine;chloride 386894 NSC679796 sensitive
hsa-miR-508-3p 9-isobutyl-6-(((2-methyl-1-naphthyl)methyl)thio)-9h-purin-2-amine 244996 NSC56452 sensitive
hsa-miR-508-3p 9-methoxy-2-methylellipticinium iodide 3086380 NSC155693 resistant
hsa-miR-508-3p 9(10h)-anthracenone (2,4-bis(hydroxy(oxido)amino)phenyl)hydrazone 305123 NSC201873 sensitive
hsa-miR-508-3p 9,10-dimethyltricyclo[10.4.0.02,7]hexadeca-1(16),2,4,6,12,14-hexaene-4,5,14,15-tetrol 382047 NSC669349 sensitive
hsa-miR-508-3p 9h-purine, 2-amino-6-(2,4-dichlorobenzylthio)-9-isobutyl- 240896 NSC47786 sensitive
hsa-miR-508-3p 9h-quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-phenyl- 4567749 NSC686553 sensitive
hsa-miR-508-3p Acetic acid;4-(2-aminocyclohexyl)imino-2-methylbenzo[f][1,3]benzoxazol-9-one 388014 NSC682436 sensitive
hsa-miR-508-3p Acronycine, 2-nitro 342903 NSC380856 sensitive
hsa-miR-508-3p Actinomycin vii 122799 NSC87222 sensitive
hsa-miR-508-3p Actinomycin x4357g methoxime 9573583 NSC237671 sensitive
hsa-miR-508-3p Androst-5-en-16.beta.-ol, 3.beta.-methoxy- (8ci) 234498 NSC34475 sensitive
hsa-miR-508-3p Antineoplastic-615538 NSC615538 sensitive
hsa-miR-508-3p Antineoplastic-92915 261051 NSC92915 sensitive
hsa-miR-508-3p Aquamycin 10971 NSC38643 sensitive
hsa-miR-508-3p Artelasticin 5471311 NSC710342 sensitive
hsa-miR-508-3p Auranofin 6333901 NSC321521 sensitive
hsa-miR-508-3p Austrocortirubin 5459130 NSC626307 sensitive
hsa-miR-508-3p Baccharin 5358645 NSC269757 sensitive
hsa-miR-508-3p Baccharinoid a-1 (busam) 5458898 NSC375726 sensitive
hsa-miR-508-3p Benzo[1,2-b:4,5-b']dithiophene-4,8-diol, dipropionate 388303 NSC682993 sensitive
hsa-miR-508-3p Benzo[1,2-b:5,4-b']dithiophene-4,8-dione, 2-acetyl- 388028 NSC682453 sensitive
hsa-miR-508-3p Benzo[1,2-b:5,4-b']dithiophene-4,8-dione, 2,5-diacetyl- 388027 NSC682452 sensitive
hsa-miR-508-3p Benzo[1,2-c:4,5-c']dipyrrole-1,3,5,7(2h,6h)-tetraimine 359178 NSC619860 sensitive
hsa-miR-508-3p Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 353644 NSC602617 sensitive
hsa-miR-508-3p Benzyl 2-(dibenzylamino)-3-phenylpropanoate 375616 NSC655438 sensitive
hsa-miR-508-3p Benzyl 3-methyl-2-[methyl-[2-[methyl-[3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoyl]amino]-3-phenylpropanoyl]amino]butanoate 375406 NSC655092 sensitive
hsa-miR-508-3p Bis(trifluoromethylsulfonyl)azanide;trihexyl(tetradecyl)phosphanium 11181836 NSC747251 sensitive
hsa-miR-508-3p Blastmycin 245869 NSC58239 sensitive
hsa-miR-508-3p Bortezomib 387447 NSC681239 approved sensitive
hsa-miR-508-3p Butanedioic acid;10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine 5351168 NSC46061 sensitive
hsa-miR-508-3p C22h12f6o6s2 389883 NSC686511 sensitive
hsa-miR-508-3p C8, carbonyl prodigiosine 135540857 NSC742417 sensitive
hsa-miR-508-3p Caracemide 54747 NSC253272 sensitive
hsa-miR-508-3p Cbmicro_021216 812842 NSC707055 sensitive
hsa-miR-508-3p Celcot rm 67277 NSC37168 sensitive
hsa-miR-508-3p Celcot rn 67241 NSC37202 sensitive
hsa-miR-508-3p Cepharanthine 10206 NSC758965 sensitive
hsa-miR-508-3p Chimaphilin 101211 NSC400245 sensitive
hsa-miR-508-3p Chlorodestruxin 370710 NSC644211 sensitive
hsa-miR-508-3p Chloroplatinum(1+); 2-diphenylphosphanyl-n,n-dimethyl-ethanamine 499568 NSC685470 sensitive
hsa-miR-508-3p Chonemorphine 54612857 NSC748909 sensitive
hsa-miR-508-3p Chromeno[2,3-f]quinolin-7-one 385093 NSC676028 resistant
hsa-miR-508-3p Cis-dichlorobis(4-methoxyphenethylamine)platinum(ii) 498558 NSC631305 sensitive
hsa-miR-508-3p Clofarabine 354624 NSC606869 resistant
hsa-miR-508-3p Clomid 3033832 NSC756698 sensitive
hsa-miR-508-3p Clothixamide maleate 44144400 NSC78714 sensitive
hsa-miR-508-3p Copper;(ne,3z)-n-[1-(6-methylpyridazin-3-yl)ethylidene]-3-azabicyclo[3.2.2]nonane-3-carbohydrazonothioate 9578854 NSC633271 sensitive
hsa-miR-508-3p Coptisine chloride 72321 NSC119754 sensitive
hsa-miR-508-3p Crambescidin 800 trihydrochloride 400719 NSC713155 sensitive
hsa-miR-508-3p Cuspidatin c 5459164 NSC636859 sensitive
hsa-miR-508-3p Cyano pyridine -p-ch3 406496 NSC724623 sensitive
hsa-miR-508-3p Cytembena 23663958 NSC104801 sensitive
hsa-miR-508-3p Dasatinib 3062316 NSC732517 approved resistant
hsa-miR-508-3p Destruxin a 122810 NSC361126 sensitive
hsa-miR-508-3p Destruxin e 107863 NSC361127 sensitive
hsa-miR-508-3p Di-p-tolyliodinium bromide 54601177 NSC8985 sensitive
hsa-miR-508-3p Dichlorobisoxinatotitanium(iv) NSC635157 sensitive
hsa-miR-508-3p Diethoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368297 NSC638842 sensitive
hsa-miR-508-3p Diethyl (E)-2-(5-methyl-2,4-dioxo-3-prop-2-ynylpyrimidin-1-yl)but-2-enedioate 5469887 NSC693986 resistant
hsa-miR-508-3p Diethyl 2-((4-(((3-chloro-2-phenyl-6-quinoxalinyl)methyl)amino)benzoyl)amino)pentanedioate 373186 NSC649150 sensitive
hsa-miR-508-3p Diethyl 2-[[4-[(3-ethoxycarbonylquinoxalin-2-yl)amino]benzoyl]amino]pentanedioate 382848 NSC670678 resistant
hsa-miR-508-3p Diethyl 2-[[4-[3-phenyl-6-(trifluoromethyl)quinoxalin-2-yl]oxybenzoyl]amino]pentanedioate 390814 NSC688816 resistant
hsa-miR-508-3p Diethylcyanine 5717105 NSC97374 sensitive
hsa-miR-508-3p Dihydro-5-azacytidine 5351280 NSC264880 sensitive
hsa-miR-508-3p Diisopropoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368058 NSC638383 sensitive
hsa-miR-508-3p Dimethyl (2S,3aS,8bR)-4-(benzenesulfonyl)-8b-(3-methylbut-2-enyl)-2,3a-dihydro-1H-pyrrolo[2,3-b]indole-2,3-dicarboxylate 385406 NSC676581 sensitive
hsa-miR-508-3p Dimethyl (E)-2-(2,4,6,8-tetramethylazulen-1-yl)but-2-enedioate 5468210 NSC666123 sensitive
hsa-miR-508-3p Dimethyl 2,2'-(pyridine-2,6-diyldicarbonyl)bis(1-methylhydrazinecarbodithioate) 375401 NSC655072 sensitive
hsa-miR-508-3p Discorhabdin g 135409045 NSC656204 sensitive
hsa-miR-508-3p Dromostanolone propionate 224004 NSC12198 sensitive
hsa-miR-508-3p Ellipticine 3213 NSC71795 resistant
hsa-miR-508-3p Ergenyl 3121 NSC93819 approved sensitive
hsa-miR-508-3p Ethyl (4s)-4-amino-5-[[(2r)-3-[4-[bis(2-chloroethyl)amino]phenyl]-1-ethoxy-1-oxopropan-2-yl]amino]-5-oxopentanoate;2,2,2-trifluoroacetic acid 388719 NSC683777 resistant
hsa-miR-508-3p Ethyl (e)-2-cyano-3-[5'-ethyl-6'-(1-hydroxyethyl)-2,2'-spirobi[1,3-dihydroindene]-5-yl]prop-2-enoate 6477478 NSC670289 sensitive
hsa-miR-508-3p Ethyl 3-(4-fluoroanilino)quinoxaline-2-carboxylate 387137 NSC680553 resistant
hsa-miR-508-3p Ethyl 3-(9-chloro-4-hydroxy-2,5,11-trimethyl-6h-pyrido[3,2-b]carbazol-3-yl)propanoate 386719 NSC679261 sensitive
hsa-miR-508-3p Ethyl 4-[[(5s,5as)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5h-[2]benzofuro[6,5-f][1,3]benzodioxol-5-yl]amino]piperidine-1-carboxylate;hydrochloride 375038 NSC653864 resistant
hsa-miR-508-3p Ethyl 4-amino-3-carbamoyl[1,2,4]triazino[4,3-a]indole-10-carboxylate 403964 NSC719735 resistant
hsa-miR-508-3p Ethyl 4-oxo-3-phenyl-[1,2,3,5]tetrazino[5,4-a]indole-10-carboxylate 396113 NSC701661 sensitive
hsa-miR-508-3p Ethyl 6-chloro-4-phenyl-2-(piperazin-1-ylmethyl)quinoline-3-carboxylate 369623 NSC641536 sensitive
hsa-miR-508-3p Ethyl 6-methyl-2-(4-methylbenzyl)-1-oxo-2-indanecarboxylate 382681 NSC670329 sensitive
hsa-miR-508-3p Ethylsulfanyl[?]one 391210 NSC690043 sensitive
hsa-miR-508-3p Eu-0000702 399169 NSC709588 resistant
hsa-miR-508-3p Ex-a776 5356520 NSC59984 sensitive
hsa-miR-508-3p Geldanamycin deriv 5458696 NSC320877 sensitive
hsa-miR-508-3p Girolline 362388 NSC626159 resistant
hsa-miR-508-3p Glemyyhyohrblt-uhfffaoysa-n 381505 NSC668261 sensitive
hsa-miR-508-3p Gnmlngdfmleynr-uhfffaoysa-n 402862 NSC717147 resistant
hsa-miR-508-3p Go-y103 1352182 NSC677240 sensitive
hsa-miR-508-3p Gw410563a 10425574 NSC756225 resistant
hsa-miR-508-3p Gw435821x 44418540 NSC756233 sensitive
hsa-miR-508-3p Helenin 72724 NSC93131 sensitive
hsa-miR-508-3p Herveline o 5459269 NSC676002 sensitive
hsa-miR-508-3p Heteromine a 391982 NSC691767 sensitive
hsa-miR-508-3p Hydroxymethoxytetrangulol 379539 NSC664214 sensitive
hsa-miR-508-3p Hymenialdisine 135413546 NSC607173 sensitive
hsa-miR-508-3p Idaayixnilonem-uhfffaoysa-n 393903 NSC696864 sensitive
hsa-miR-508-3p Idebenone 12881464 NSC759228 approved sensitive
hsa-miR-508-3p Iejimalide a. 5473233 NSC724579 sensitive
hsa-miR-508-3p Insariotoxin 6711181 NSC138780 sensitive
hsa-miR-508-3p Isobaccharin 5358646 NSC269760 sensitive
hsa-miR-508-3p Ixabepilone 6445540 NSC747973 sensitive
hsa-miR-508-3p J3.547.609a 364763 NSC631522 sensitive
hsa-miR-508-3p J3.572.907k 396709 NSC703318 sensitive
hsa-miR-508-3p Juncusol deriv (compound 1) 24200489 NSC378135 sensitive
hsa-miR-508-3p Kinetin riboside 3832 NSC120958 resistant
hsa-miR-508-3p Kuc110490n 377410 NSC658853 sensitive
hsa-miR-508-3p Leucinostatine d 5459065 NSC608984 sensitive
hsa-miR-508-3p Lmpk12050091 165203 NSC646923 sensitive
hsa-miR-508-3p Lmpk12113330 5386962 NSC618933 sensitive
hsa-miR-508-3p Ls-123342 5469111 NSC683328 sensitive
hsa-miR-508-3p M-232 403374 NSC718170 sensitive
hsa-miR-508-3p Mecal 67686 NSC150555 sensitive
hsa-miR-508-3p Melampodinin 5359028 NSC294600 sensitive
hsa-miR-508-3p Mercury, tetrakis(acetato)(2,3,4,5-thiophenetetrayl)tetra- 16683745 NSC145801 sensitive
hsa-miR-508-3p Methyl-[2-methyl-2-(4-methylphenyl)propyl]-diphenylphosphanium;iodide 20835892 NSC176098 sensitive
hsa-miR-508-3p Methyl (2E)-2-methoxyimino-2-[2-[[2-(trifluoromethyl)phenoxy]methyl]phenyl]acetate 6520923 NSC720765 sensitive
hsa-miR-508-3p Methyl (2s)-2-[[4-[[[(e)-3-(3-phenoxyphenyl)prop-2-enoyl]amino]methyl]benzoyl]amino]-3-phenylpropanoate 5470471 NSC702117 sensitive
hsa-miR-508-3p Methyl (2s)-3-phenyl-2-[[4-[[[(e)-3-(2-phenyl-1,3-thiazol-4-yl)prop-2-enoyl]amino]methyl]benzoyl]amino]propanoate 5470488 NSC702134 sensitive
hsa-miR-508-3p Methyl (2s)-4-methylsulfanyl-2-[[4-[[[(e)-3-(3-phenoxyphenyl)prop-2-enoyl]amino]methyl]benzoyl]amino]butanoate 5470490 NSC702136 sensitive
hsa-miR-508-3p Methyl (2s,3s)-2-(4-hydroxyphenyl)-5-[(e)-3-methoxy-3-oxoprop-1-enyl]-2,3-dihydro-1-benzofuran-3-carboxylate 5468718 NSC675006 sensitive
hsa-miR-508-3p Methyl (e)-2-acetyl-5-(4-chlorophenyl)hex-4-enoate 5387098 NSC620324 sensitive
hsa-miR-508-3p Methyl (e)-3-[2-[[methyl-(4-methylphenyl)-oxo-lambda6-sulfanylidene]amino]phenyl]prop-2-enoate 24202623 NSC716715 sensitive
hsa-miR-508-3p Methyl (E)-4-[4,5-dichloro-2-[2-[methyl-[(1S,2S)-2-pyrrolidin-1-ylcyclohexyl]amino]-2-oxoethyl]anilino]-4-oxobut-2-enoate 54611534 NSC707465 sensitive
hsa-miR-508-3p Methyl 10-acetyl-3-(4-methylphenyl)sulfonyl-9-(2-methylprop-1-enyl)-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13),11-pentaene-11-carboxylate NSC621968 sensitive
hsa-miR-508-3p Methyl 11h-pyrido[2,3-a]carbazole-5-carboxylate 13776879 NSC740203 resistant
hsa-miR-508-3p Methyl 2-((1-oxo-1,2,3,5,6,7-hexahydro-s-indacen-2-yl)methyl)benzoate 382689 NSC670337 sensitive
hsa-miR-508-3p Methyl 2-[(1r,2r,6s,7s)-3,5-dithiatricyclo[5.2.1.02,6]dec-8-en-4-ylidene]-1,3-dithiole-4-carboxylate 403847 NSC719381 sensitive
hsa-miR-508-3p Methyl 2-[[2-[[2-[[5-[(4-chlorophenoxy)methyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetyl]amino]acetyl]amino]acetate 395267 NSC699745 sensitive
hsa-miR-508-3p Methyl 3-[(5Z)-5-[[3-methoxy-5-(1H-pyrrol-2-yl)-1H-pyrrol-2-yl]methylidene]-2,4-dimethylpyrrol-3-yl]propanoate 155811421 NSC755119 sensitive
hsa-miR-508-3p Methyl 3-[4-[[(6aS)-2-methoxy-11-oxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butyl]-2-(1-methylindol-2-yl)benzimidazole-5-carboxylate 45028743 NSC744020 sensitive
hsa-miR-508-3p Methyl 4-[(1,4-dihydroxynaphthalen-2-yl)methylamino]benzoate 387584 NSC681541 sensitive
hsa-miR-508-3p Methyl 4-[(e)-(5-methyl-2-phenylpyrazol-3-yl)iminomethyl]benzoate 9572413 NSC715229 sensitive
hsa-miR-508-3p Methyl 4-methyl-2-((6-methyl-1-oxo-2,3-dihydro-1h-inden-2-yl)methyl)benzoate 385695 NSC677041 sensitive
hsa-miR-508-3p Methyl N-(4-chlorophenyl)sulfonyl-N'-[3-[[[(4-chlorophenyl)sulfonylamino]-methylsulfanylmethylidene]amino]propyl]carbamimidothioate 382843 NSC670673 sensitive
hsa-miR-508-3p Methyl n-[6-[(4-fluorophenyl)sulfonylamino]-1h-benzimidazol-2-yl]carbamate 404125 NSC720248 sensitive
hsa-miR-508-3p Methyl(2r,3as)-2-[(4-hydroxyphenyl)methyl]-1,3,3a,4-tetrahydropyrazolo[1,5-a]indole-2-carboxylate 398179 NSC707774 sensitive
hsa-miR-508-3p Methylene blue 6099 NSC617593 approved sensitive
hsa-miR-508-3p Midostaurin 9829523 NSC800791 approved resistant
hsa-miR-508-3p N'-(2-hydroxy-5-(hydroxy(oxido)amino)benzylidene)-1-piperidinecarbothiohydrazide 135484941 NSC689530 resistant
hsa-miR-508-3p N'-(4-chloroanilino)pyrazine-2-carboximidamide 9572225 NSC709079 sensitive
hsa-miR-508-3p N'-[(3,4-dichlorophenyl)methyl]-n,n'-dimethyl-n-(2-pyrrolidin-1-ylethyl)ethane-1,2-diamine;hydrobromide 398577 NSC708546 sensitive
hsa-miR-508-3p N'-[1-(1-benzothiophen-2-yl)cyclohexyl]-n-methylpropane-1,3-diamine;(e)-but-2-enedioic acid 54611499 NSC708074 sensitive
hsa-miR-508-3p N'-[8-(4-hydroxy-3,5-dimethoxyphenyl)-7-methyl-7,8-dihydro-6h-[1,3]dioxolo[4,5-g]chromen-6-yl]-4-methylbenzenesulfonohydrazide 383134 NSC671175 sensitive
hsa-miR-508-3p N'-benzylidene-4-((1-methyl-2,5-dioxo-4-imidazolidinylidene)methyl)benzenesulfonohydrazide 9571572 NSC683747 sensitive
hsa-miR-508-3p N-(2-((((4-methoxyphenyl)diazenyl)carbonyl)amino)-4-methylpentanoyl)leucine 386435 NSC678403 sensitive
hsa-miR-508-3p N-(2-methoxyphenyl)-5-methyl-4-oxo-3-(2-phenoxyethyl)thieno[2,3-d]pyrimidine-6-carboxamide 1178182 NSC730214 sensitive
hsa-miR-508-3p N-(2,4-dichlorophenyl)-9-methyl-11-oxo-8-oxa-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene-12-carboxamide 399143 NSC709562 resistant
hsa-miR-508-3p N-(3-acetylphenyl)-2-[2-(4-amino-5-sulfanylidene-1H-1,2,4-triazol-3-yl)hydrazinyl]-2-oxoacetamide 3000679 NSC642049 sensitive
hsa-miR-508-3p N-(3-chloro-1,4-dioxonaphthalen-2-yl)-4-[2-[(3,4-dioxonaphthalen-2-yl)amino]phenyl]-2,4-dioxobutanamide 369475 NSC641245 sensitive
hsa-miR-508-3p N-(3-chloro-1,4-dioxonaphthalen-2-yl)-4-naphthalen-2-yl-2,4-dioxo-3-(3-oxo-1H-2-benzofuran-1-yl)butanamide 369463 NSC641233 sensitive
hsa-miR-508-3p N-(3-hydroxy-7-methyl-5,8-dioxo-2,3-dihydro-1H-pyrrolo[1,2-a]benzimidazol-6-yl)acetamide 374007 NSC651081 sensitive
hsa-miR-508-3p N-(4-((4-anilino-1-benzyl-4-piperidinyl)ethynyl)-1-benzyl-4-piperidinyl)-n-phenylamine 379997 NSC665299 sensitive
hsa-miR-508-3p N-(4-(1-adamantyl)-1,3-thiazol-2-yl)-7-hydroxy-2-oxo-2h-chromene-3-carboxamide 5466102 NSC675799 sensitive
hsa-miR-508-3p N-(7-chloroquinolin-4-yl)-N',N'-diethyl-2-(4-methoxyphenyl)butane-1,4-diamine 223171 NSC13300 sensitive
hsa-miR-508-3p N-(7-chloroquinolin-4-yl)-n',n'-diethyl-2-phenylbutane-1,4-diamine 222939 NSC10037 sensitive
hsa-miR-508-3p N-[(E)-1-pyridin-2-ylbutylideneamino]-3-azabicyclo[3.2.2]nonane-3-carbothioamide 5921457 NSC335791 sensitive
hsa-miR-508-3p N-[(r)-1-phenylethyl]-4-[[[3-(3-phenoxyphenyl)acryloyl]amino]methyl]benzamide 5470483 NSC702129 resistant
hsa-miR-508-3p N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-2-(3-propan-2-yloxyphenyl)-4H-pyrido[4,3-e][1,2,4]thiadiazin-3-imine 135426715 NSC710895 sensitive
hsa-miR-508-3p N-[2-(3,4-dichlorophenyl)ethyl]-n,n'-dimethyl-n'-(2-pyrrolidin-1-ylethyl)ethane-1,2-diamine;hydrobromide 398585 NSC708550 sensitive
hsa-miR-508-3p N-[2-(3,4-dihydroxyphenyl)ethyl]-3-phenylpropanamide 383148 NSC671189 sensitive
hsa-miR-508-3p N-[2-(4-acetylpiperazin-1-yl)ethyl]-3-(3-chloro-5-hydroxyphenyl)-4-pyridin-4-ylpyrazole-1-carboxamide 53483672 NSC753193 sensitive
hsa-miR-508-3p N-[2-(dimethylamino)ethyl]-2-pyridin-4-yl-1H-benzimidazole-4-carboxamide;hydrochloride 386523 NSC678932 sensitive
hsa-miR-508-3p N-[2-[methyl-[2-[(2-phenylquinoline-4-carbonyl)amino]ethyl]amino]ethyl]-2-phenylquinoline-4-carboxamide 384377 NSC674085 sensitive
hsa-miR-508-3p N-[3-(4-benzamidopyrrolo[3,2-c]pyridin-1-yl)phenyl]-3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzamide 70692461 NSC755426 sensitive
hsa-miR-508-3p N-[3-[2-[(7-chloroquinolin-4-yl)amino]ethyl-ethylamino]propyl]-2-[7-(dimethylamino)-2-oxochromen-4-yl]acetamide 49856402 NSC754328 sensitive
hsa-miR-508-3p N-[4-[2-(2,4-dinitrophenyl)-3-(3-ethoxy-4-hydroxyphenyl)-3,4-dihydropyrazol-5-yl]phenyl]-2-methyl-5-nitrobenzenesulfonamide 402369 NSC716281 resistant
hsa-miR-508-3p N-[8-hydroxy-7-(piperidin-1-ylmethyl)quinolin-5-yl]acetamide 279612 NSC130876 sensitive
hsa-miR-508-3p N-butyltriphenylphosphonium bromide 159628 NSC59684 sensitive
hsa-miR-508-3p N-ethyl-2-[(e)-2-(5-nitrofuran-2-yl)ethenyl]quinoline-4-carboxamide 5471900 NSC715224 sensitive
hsa-miR-508-3p N,N'-bis[5-[[5-[(3-amino-3-iminopropyl)carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]butanediamide;hydrochloride 367397 NSC637124 sensitive
hsa-miR-508-3p N,N'-bis[5-[[5-[(3-amino-3-iminopropyl)carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]octanediamide;hydrochloride 365885 NSC633963 sensitive
hsa-miR-508-3p N,n-bis(2-chloroethyl)-4-[(e)-2-(1-ethyl-6-iodoquinolin-1-ium-2-yl)ethenyl]aniline;iodide 54608102 NSC640083 sensitive
hsa-miR-508-3p N,n-dibenzyl-4-(4-hydroxy-2,6-dimethyl-5-pyrimidinyl)-1-piperazinesulfonamide 135426540 NSC673104 resistant
hsa-miR-508-3p N,n-diethylethanamine;6-[2-(4-hydroxy-3-nitrophenyl)ethylamino]-1h-benzimidazole-4,7-dione 24202492 NSC673320 sensitive
hsa-miR-508-3p N~4~-(8-((2-amino-6-chloro-4-pyrimidinyl)amino)octyl)-6-chloro-2,4-pyrimidinediamine 363998 NSC629620 sensitive
hsa-miR-508-3p Nabor orange r 135436499 NSC4434 sensitive
hsa-miR-508-3p Naphth[2,3-d]oxazol-9-one, 2-methyl-4-(phenylimino)- 160386 NSC650573 sensitive
hsa-miR-508-3p Naphthalene-1,2-dione, 1,2-dihydro-4-[(3-pyridinyl)amino]- 367787 NSC637729 sensitive
hsa-miR-508-3p Naphtho[2,3-d]-1,3-dioxepin-6,11-dione, 4-methyl- NSC626868 sensitive
hsa-miR-508-3p Naphtho[2,3-d]oxazole-4,9-dione, 2-(1,1-dimethylethyl)- 370622 NSC643915 sensitive
hsa-miR-508-3p Naphtho[2,3-f]quinoxaline-7,12-dione, 3-hydroxy-2-methyl- 371563 NSC645892 resistant
hsa-miR-508-3p Navan 941650 NSC108165 sensitive
hsa-miR-508-3p Neuro_000410 383131 NSC671172 sensitive
hsa-miR-508-3p None 12201866 NSC179207 sensitive
hsa-miR-508-3p None 12201866 NSC179207 resistant
hsa-miR-508-3p NSC600301 NSC600301 sensitive
hsa-miR-508-3p NSC617743 NSC617743 sensitive
hsa-miR-508-3p NSC618857 NSC618857 resistant
hsa-miR-508-3p NSC621335 NSC621335 sensitive
hsa-miR-508-3p NSC621339 NSC621339 sensitive
hsa-miR-508-3p NSC622115 NSC622115 sensitive
hsa-miR-508-3p NSC625492 NSC625492 sensitive
hsa-miR-508-3p NSC657270 NSC657270 sensitive
hsa-miR-508-3p NSC658455 NSC658455 sensitive
hsa-miR-508-3p NSC676495 NSC676495 resistant
hsa-miR-508-3p NSC695636 NSC695636 sensitive
hsa-miR-508-3p P-chloranilinum[bis(p-chloraniline)dioxalatoruthenate(iii)] 54608061 NSC631477 sensitive
hsa-miR-508-3p Pentyl 6-(chloromethyl)-2-oxo-2h-chromene-3-carboxylate 402498 NSC716524 sensitive
hsa-miR-508-3p Phenanthrene-9,10-diimine 2981 NSC684322 sensitive
hsa-miR-508-3p Phlorone 8718 NSC15309 sensitive
hsa-miR-508-3p Phosphonium, (3-bromopropyl)triphenyl- bromide 2723862 NSC84074 sensitive
hsa-miR-508-3p Piperidinium, 1,1-didodecyl-3-methyl-, bromide 21144608 NSC194124 sensitive
hsa-miR-508-3p Pmp (van) 72508 NSC1906 sensitive
hsa-miR-508-3p Primaquine phosphate 359247 NSC149765 sensitive
hsa-miR-508-3p Propyl gallate 4947 NSC2626 resistant
hsa-miR-508-3p Purpureagitosid 401298 NSC714604 resistant
hsa-miR-508-3p Pyrrole-3-carbonitrile, 2-(1-isoquinolyl)-5-phenyl- 272334 NSC116640 sensitive
hsa-miR-508-3p S-(diisopropylarsino)-3-mercapto-1,2-propanediol 406478 NSC724599 sensitive
hsa-miR-508-3p Saponaceolide a 6477038 NSC624482 sensitive
hsa-miR-508-3p Selumetinib 10127622 NSC741078 approved sensitive
hsa-miR-508-3p Sergeolide,desacetyl 125729 NSC364170 sensitive
hsa-miR-508-3p Spiro[3,6,7,8-tetrahydro-1h-cyclopenta[a]naphthalene-2,2'-3,6,7,8-tetrahydro-1h-cyclopenta[g]naphthalene]-5',9-dione 382635 NSC670284 sensitive
hsa-miR-508-3p Spiro[as-indacene-2(1h),2'(1'h)-[s]indacen]-1-one, 4'-acetyl-3,3',5',6,6',7,7',8-octahydro- 385658 NSC677004 sensitive
hsa-miR-508-3p Spiro[s-indacene-2(5h),2'-[2h]inden]-5-one, 1,1',3,3',6,7-hexahydro- 382726 NSC670404 sensitive
hsa-miR-508-3p Stannane, chlorohydroxydiphenyl- 6333579 NSC269599 sensitive
hsa-miR-508-3p Staurosporine 5459111 NSC618487 resistant
hsa-miR-508-3p Stk213636 236554 NSC39135 sensitive
hsa-miR-508-3p Stk366297 242249 NSC50648 sensitive
hsa-miR-508-3p Stk673166 NSC717468 sensitive
hsa-miR-508-3p Stk766820 381153 NSC667471 sensitive
hsa-miR-508-3p Stl323035 383655 NSC672073 sensitive
hsa-miR-508-3p Stl338719 393017 NSC694265 resistant
hsa-miR-508-3p Streptomyces antibiotic sf-2446-a-1 197261 NSC624488 sensitive
hsa-miR-508-3p Strychnine, 11-benzylidene 5381711 NSC121868 sensitive
hsa-miR-508-3p Sudan red 11980862 NSC11241 sensitive
hsa-miR-508-3p Tacacoside a2 496860 NSC700649 sensitive
hsa-miR-508-3p Tetra(isobutenyl)antimony bromide NSC651199 sensitive
hsa-miR-508-3p Tetratert-butyl 8,11-dimethoxytricyclo[4.3.3.01,6]dodeca-7,10-diene-7,9,10,12-tetracarboxylate 362411 NSC626176 sensitive
hsa-miR-508-3p Tetrocarcin a, sodium salt 6474412 NSC333856 sensitive
hsa-miR-508-3p Tgf.alpha.-pe40 NSC623436 resistant
hsa-miR-508-3p Thiazolo[3,2-f]phenanthridinium, 3-phenyl- perchlorate 5351215 NSC98904 sensitive
hsa-miR-508-3p Thioperoxydicarbonic diamide, tetramethyl- 5455 NSC622696 sensitive
hsa-miR-508-3p Toxin .delta.53l NSC671526 resistant
hsa-miR-508-3p Tp4ek NSC676497 resistant
hsa-miR-508-3p Tptz 9283 NSC5053 sensitive
hsa-miR-508-3p Triacetyl crambescidin 800 hydrochloride 400721 NSC713156 sensitive
hsa-miR-508-3p Tributyrin 6050 NSC661583 sensitive
hsa-miR-508-3p Triciribine phosphate 43860 NSC280594 resistant
hsa-miR-508-3p Triphenyl(2-triphenylphosphaniumylethyl)phosphanium 2785216 NSC64111 sensitive
hsa-miR-508-3p Tryptanthrin 73549 NSC349447 sensitive
hsa-miR-508-3p Tunicamycin 16727450 NSC177382 resistant
hsa-miR-508-3p Ver a 5351232 NSC126728 sensitive
hsa-miR-508-3p Viridomycin NSC236657 resistant
hsa-miR-508-3p Vorinostat 5311 NSC701852 approved sensitive
hsa-miR-508-3p Wln: g-sn-gr&r 14342 NSC405640 sensitive
hsa-miR-508-3p Xnivbtjmwlisex-djkkodmxsa-n 9571538 NSC681776 resistant
hsa-miR-508-3p Xylosyl a NSC7359 resistant
hsa-miR-508-3p Z198955462 135528004 NSC744178 sensitive
hsa-miR-508-3p Z28714792 2671841 NSC746248 sensitive
hsa-miR-508-3p Z48861686 4784054 NSC745813 sensitive
hsa-miR-508-3p Zinc pyrithione NSC68093 sensitive
hsa-miR-508-3p Cisplatin 5460033 NSC119875 approved sensitive Low Gastric Cancer tissue and cell line (SGC7901)
hsa-miR-508-3p Doxorubicin 31703 NSC123127 approved sensitive Low Gastric Cancer tissue and cell line (SGC7901)
hsa-miR-508-3p Fluorouracil 3385 NSC19893 approved sensitive Low Gastric Cancer tissue and cell line (SGC7901)
hsa-miR-508-3p Vincristine 5978 approved sensitive Low Gastric Cancer tissue and cell line (SGC7901)
hsa-miR-508-3p Doxorubicin 31703 NSC123127 approved resistant High Chronic Myelogenous Leukemia cell line (K562)
hsa-miR-508-3p Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (SW1990)
hsa-miR-508-3p Cisplatin 5460033 NSC119875 approved sensitive High Ovarian Cancer tissue
hsa-miR-508-3p Ponatinib 24826799 NSC758487 approved resistant High Chronic Myelogenous Leukemia leukemia stem cells
hsa-miR-508-3p Imatinib 5291 NSC743414 approved resistant High Chronic Myelogenous Leukemia leukemia stem cells
hsa-miR-508-3p Dabrafenib 44462760 NSC764134 approved sensitive High Melanoma cell line (A375)
hsa-miR-508-3p Docetaxel 148124 NSC628503 approved resistant High Breast Cancer cell line (MDA-MB-231, MCF-7)
hsa-miR-508-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (A375)
hsa-miR-508-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKVO3ip1)
hsa-miR-508-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM43)
hsa-miR-508-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM17)
hsa-miR-508-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM16)
hsa-miR-508-3p Testosterone+Anastrozole resistant cell line (MCF-7)
hsa-miR-508-3p Sunitinib 5329102 NSC750690 approved resistant tissue (CardA)
hsa-miR-508-3p Pegylated interferon alpha+Ribavirin resistant tissue (chronic hepatitis C)
hsa-miR-508-3p Doxorubicin 31703 NSC123127 approved resistant cell line (K562)
hsa-miR-508-3p Platinum 23939 sensitive tissue (non-small cell lung cancer)
hsa-miR-508-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-508-3p Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)

Error report submission